{
    "data": [
        {
            "title": "Assessing Whether Honda Motor (TSE:7267) Still Looks Undervalued After Recent Share Price Momentum",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Why Honda Motor (TSE:7267) is Back on Investors‚Äô Radar</h2> <p>Honda Motor (TSE:7267) has recently drawn fresh attention as its shares moved in positive territory over the past week and month, prompting investors to reassess its current valuation and fundamentals.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/jp/automobiles/tse-7267/honda-motor-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Honda Motor.</a></p> <p>At a share price of ¬•1,584.5, Honda Motor‚Äôs recent 7-day share price return of 2.69% and 30-day share price return of 5.63% sit against a 1-year total shareholder return of 18.99%. This suggests that short term momentum is building on top of longer term gains.</p> <p>If this has you looking beyond a single automaker, it could be a good moment to scan companies tied to electrification and infrastructure, starting with our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_power_grid\" href=\"https://simplywall.st/discover/investing-ideas/473750/power-grid-technology-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">23 power grid technology and infrastructure stocks</a>.</p> <p>With Honda trading at ¬•1,584.5 and data pointing to an estimated intrinsic discount of around 12% and a price target gap of roughly 8%, investors may ask whether there is still a buying opportunity here or whether the market is already pricing in future growth.</p> <h2>Most Popular Narrative: 8.5% Undervalued</h2> <p>Honda Motor‚Äôs most followed narrative pins fair value at ¬•1,732.16 versus the last close of ¬•1,584.5, framing the current valuation gap around long term earnings power and capital allocation.</p> <blockquote> <p><em>Ongoing cost optimization through price revisions, operational efficiencies, and expanding use of common platforms across models is improving cost structure and profitability, which will likely support higher long-term net margins and earnings stability even amidst short-term pressures from tariffs and currency fluctuations.</em></p> </blockquote> <p><em>Read the complete narrative.</em> <a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/l8abuawg-7267-share-buyback-completion-and-self-driving-collaboration-will-drive-upside\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></p> <p>Want to see what is sitting behind that margin story? The narrative leans on modest revenue growth, firmer profitability, and a lower future earnings multiple than many global peers. The full set of assumptions is where the valuation really gets interesting.</p> <p><strong>Result: Fair Value of ¬•1,732.16 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/l8abuawg-7267-share-buyback-completion-and-self-driving-collaboration-will-drive-upside\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, that margin story can quickly change if EV related losses stay high or if pressure on automobile sales in key Asian and European markets persists.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/jp/automobiles/tse-7267/honda-motor-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Honda Motor narrative.</a></p> <h2>Next Steps</h2> <p>If this mix of optimism and concern feels familiar, take a closer look at the numbers now and shape your own view with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/jp/automobiles/tse-7267/honda-motor-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 3 important warning signs</a>.</p> <h2>Ready for more investment ideas?</h2> <p>If Honda has you rethinking your watchlist, do not stop here. Use the Simply Wall St Screener to surface focused ideas that match how you like to invest.</p> <ul> <li>Target potential value opportunities by scanning companies that currently look mispriced relative to their fundamentals through our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/jp\" rel=\"noopener noreferrer\" target=\"_blank\">20 high quality undervalued stocks</a>.</li> <li>Prioritize income potential by searching for companies with robust payouts using our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/jp\" rel=\"noopener noreferrer\" target=\"_blank\">12 dividend fortresses</a> to spot those that may suit a yield focused portfolio.</li> <li>Reduce portfolio stress by concentrating on financially resilient names through our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/jp\" rel=\"noopener noreferrer\" target=\"_blank\">57 resilient stocks with low risk scores</a>, highlighting businesses with comparatively lower risk scores.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Honda Motor might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/jp/automobiles/tse-7267/honda-motor-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 08:16:02",
            "link": "https://simplywall.st/stocks/jp/automobiles/tse-7267/honda-motor-shares/news/assessing-whether-honda-motor-tse7267-still-looks-undervalue",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At Impinj (PI) Valuation After Cautious Guidance And Weaker Near Term Outlook",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Impinj (PI) is back in focus after quarterly revenue landed in line with expectations, but management‚Äôs guidance for the coming quarter fell well short, citing inventory normalization, softer retail demand, and modest pricing pressure.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/semiconductors/nasdaq-pi/impinj\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Impinj.</a></p> <p>The weak guidance has already affected sentiment, with a 30 day share price return of negative 24.08% and a year to date share price return of negative 31.67%. At the same time, the 1 year total shareholder return is 34.37%, which suggests that recent momentum has faded after a strong prior run.</p> <p>If this earnings setback has you reassessing growth stories in tech hardware, it could be a good moment to widen your search and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_ai_infrastructure\" href=\"https://simplywall.st/discover/investing-ideas/473744/ai-infrastructure-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">33 AI infrastructure stocks</a> as another way to find potential opportunities.</p> <p>With Impinj shares down sharply after cautious guidance but still up 34.37% over the past year, the key question now is simple: are you looking at a reset that leaves the stock undervalued, or is the market already pricing in future growth?</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 49.1% Undervalued</h2> <p>Impinj last closed at $122.83 while the most followed narrative pegs fair value around $241.11, setting up a wide gap for investors to examine.</p> <blockquote> <p><em>Expanding deployment of RFID solutions for food traceability and freshness especially at the item level driven by pilots with major retailers presents a multi-year growth opportunity. This trend is underpinned by regulatory and consumer demand for improved traceability and waste reduction, which is already leading to additional pilot programs and is expected to ramp into meaningful unit volumes in 2026 and beyond, supporting outsized future revenue growth.</em></p> </blockquote> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/hia05y9t-analysts-raise-impinj-price-target-as-guidance-and-valuation-metrics-show-stability\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></p> <p>Curious what justifies that higher fair value? The narrative leans heavily on fast compounding revenues, rising profit margins, and a premium future earnings multiple. The mix matters.</p> <p><strong>Result: Fair Value of $241.11 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/hia05y9t-analysts-raise-impinj-price-target-as-guidance-and-valuation-metrics-show-stability\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, you also have to weigh risks such as customer concentration in retail and logistics, along with the possibility that new RFID use cases scale more slowly than expected.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/semiconductors/nasdaq-pi/impinj\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Impinj narrative.</a></p> <h2>Another View: Sales Multiple Flags a Rich Price</h2> <p>While the narrative and our fair value estimate suggest Impinj is trading roughly 31.4% below fair value, the P/S ratio tells a different story. At 10.3x sales versus a fair ratio of 7.4x, the shares look expensive, and also pricier than the US Semiconductor industry at 6.2x and peers at 5.9x. The question is whether the discount to fair value is real, or simply a function of optimistic growth assumptions.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/us/semiconductors/nasdaq-pi/impinj/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/semiconductors/nasdaq-pi/impinj/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:PI P/S Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/61b82bc4-6ec3-4fe6-9c2c-521c7acc424c/chart/ps-multiple-vs-industry?date=2026-02-27\" width=\"746\"/></a><figcaption>NasdaqGS:PI P/S Ratio as at Feb 2026</figcaption></figure><p> </p><h2>Next Steps</h2> <p>Mixed messages on value and risk here, right? If you want to move quickly but confidently, check the full picture with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/semiconductors/nasdaq-pi/impinj\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 1 important warning sign</a>.</p> <h2>Want more investment ideas before you move on?</h2> <p>If Impinj has you questioning what to do next, do not stop here. Widen your options and let a few focused stock lists sharpen your watchlist.</p> <ul> <li>Spot potential bargains early by scanning <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 24 high quality undiscovered gems</a> that are quietly building strong fundamentals before they hit everyone‚Äôs radar.</li> <li>Strengthen your downside protection by reviewing <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> that score well on resilience and more measured risk profiles.</li> <li>Build a core watchlist around quality financial footing by checking <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> for companies with sturdier balance sheets and healthier fundamentals.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-28 08:16:02",
            "link": "https://simplywall.st/stocks/us/semiconductors/nasdaq-pi/impinj/news/a-look-at-impinj-pi-valuation-after-cautious-guidance-and-we",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Reddit UK Child Data Fine Puts Compliance And Valuation In Focus",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>UK Information Commissioner's Office fines Reddit for failures in protecting children's personal data and privacy.</li> <li>Regulator cites insufficient age checks and risk assessments on the platform prior to January 2025.</li> <li>Reddit plans to appeal the decision, putting its data practices and user protections under closer scrutiny.</li> </ul> <p>For investors watching NYSE:RDDT, this case puts Reddit's content and data practices in the spotlight alongside its financial profile. The stock trades at $151.25, with a 3.5% return over the past week, a 22.9% decline over the past 30 days, and a 37.5% decline year to date. These moves indicate that sentiment around the name has been shifting quickly.</p> <p>Regulatory action of this kind can influence how a platform shapes age checks, data usage, and product decisions. As Reddit appeals, you may want to monitor how the company updates its policies, communicates with users, and manages any follow up from other regulators, since those responses could affect its risk profile and brand over time.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/media/nyse-rddt/reddit/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Reddit</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/RDDT\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Reddit.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/media/nyse-rddt/reddit\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:RDDT 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/09919f4e-ab2c-47af-9b71-64116a71a958/chart/quote-price?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:RDDT 1-Year Stock Price Chart</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_financial_health\" href=\"https://www.simplywall.st/stocks/us/media/nyse-rddt/reddit/health\" rel=\"noopener noreferrer\" target=\"_blank\">Is Reddit's balance sheet strong enough for future acquisitions? Dive into our detailed financial health analysis.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Investor Checklist: How This Fine Fits Into the Reddit Story</h2> <h3>Quick Assessment</h3> <ul> <li><strong>‚úÖ Price vs Analyst Target</strong>: At $151.25 versus a consensus target of about $233.22, the price sits roughly 35% below what analysts are modeling.</li> <li><strong>‚úÖ Simply Wall St Valuation</strong>: Simply Wall St currently flags Reddit as trading about 58.4% below its estimated fair value.</li> <li><strong>‚ùå Recent Momentum</strong>: The 30 day return of roughly 23% decline shows weak short term sentiment around the stock.</li> </ul> <p>There is only one way to know the right time to buy, sell or hold Reddit. Head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/media/nyse-rddt/reddit/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of Reddit's Fair Value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The UK fine puts Reddit's approach to handling minors' data in focus, which connects directly to trust, engagement and advertiser comfort on the platform.</li> <li>üìä Watch how management talks about compliance spending, product changes for age checks and any impact on user metrics in future updates.</li> <li>‚ö†Ô∏è The key risk is that other regulators review Reddit's practices, which could bring extra costs, product restrictions or further reputational pressure.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/media/nyse-rddt/reddit\" rel=\"noopener noreferrer\" target=\"_blank\">complete Reddit analysis</a>. Alternatively, you can check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/RDDT\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Reddit</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-28 08:16:01",
            "link": "https://simplywall.st/stocks/us/media/nyse-rddt/reddit/news/reddit-uk-child-data-fine-puts-compliance-and-valuation-in-f",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Carnival Millions Launch And Ship Redeployment Reshape Onboard Revenue Story",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Carnival Cruise Line, part of Carnival Corporation &amp; (NYSE:CCL), has launched \"Carnival Millions\", described as the cruise industry's first fleetwide interactive lottery across its North American and European ships.</li> <li>The company is also redeploying the Carnival Adventure ship from Australia to North America, citing regulatory uncertainty and cost pressures in the Australian market.</li> </ul> <p>Carnival Corporation &amp; (NYSE:CCL) is focusing on new onboard entertainment with Carnival Millions, a lottery style product that runs across its fleet in North America and Europe. For you as an investor, this highlights an emphasis on guest engagement and potential incremental revenue from non ticket spending at a time when cruise operators are refining their onboard offerings.</p> <p>At the same time, moving Carnival Adventure from Australia to North America shows how management is adjusting deployment in response to regulation and operating costs in different regions. For your watchlist, the combination of a new entertainment product and a shift in ship positioning provides additional data points on how CCL is positioning its brand and fleet in key cruise markets.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-ccl/carnival-corporation/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Carnival Corporation &amp;</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/CCL\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on Carnival Corporation &amp;.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-ccl/carnival-corporation/future\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CCL Earnings &amp; Revenue Growth as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/106688cf-a61b-411b-8be3-747df2075482/chart/earnings-and-revenue-growth?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:CCL Earnings &amp; Revenue Growth as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_hidden_strengths\" href=\"https://www.simplywall.st/stocks/us/consumer-services/nyse-ccl/carnival-corporation\" rel=\"noopener noreferrer\" target=\"_blank\">4 things going right for Carnival Corporation &amp; that this headline doesn't cover.</a></p> <p>Carnival Millions points to a push to grow higher margin, non ticket revenue by turning the Carnival HUB app into more of a real time entertainment and spending platform. For you, that sits alongside price changes to gratuities and beverage packages as part of a broader focus on onboard yield. The linked lottery format could also help differentiate Carnival from large peers like Royal Caribbean and Norwegian Cruise Line, which are also vying to keep guests spending once on board.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>How This Fits Into The Carnival Corporation &amp; Narrative</h3> <ul> <li>The rollout of a fleetwide interactive lottery supports the narrative around stronger guest experience and higher onboard spend, which has been highlighted as a driver of revenue and margin improvement.</li> <li>Shifting Carnival Adventure out of Australia in response to regulation and costs illustrates how regional pressures can affect capacity management, which the narrative treats as a key tool for maintaining pricing power.</li> <li>The use of app based, real time gaming and linked experiences across ships adds a digital engagement angle that is not fully reflected in the focus on private destinations and loyalty programs.</li> </ul> <p>Knowing what a company is worth starts with understanding its story.\n                        <a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/narratives/20trwq8f-ccl-record-bookings-and-improved-guidance-will-drive-upside-into-2026\" rel=\"noopener noreferrer\" target=\"_blank\">Check out one of the top narratives in the Simply Wall St Community for Carnival Corporation &amp;</a> to help decide what it's worth to you.</p> <h3>The Risks and Rewards Investors Should Consider</h3> <ul> <li>‚ö†Ô∏è Greater reliance on gaming and lottery style products could attract regulatory scrutiny or reputational questions in some markets.</li> <li>‚ö†Ô∏è Redeploying a ship away from Australia signals that higher regional costs and regulatory changes can affect route economics and future capacity decisions.</li> <li>üéÅ A fleetwide lottery tied to the Carnival HUB app may support higher onboard spend per guest and deeper engagement during each sailing.</li> <li>üéÅ Fine tuning ship deployment toward North America could align capacity with routes where demand and cost structures may be more favorable.</li> </ul> <h3>What To Watch Going Forward</h3> <p>From here, you may want to watch how quickly Carnival Millions is adopted across the fleet, how frequently guests participate, and whether management starts to call out lottery related revenue separately. On the deployment side, any further comments on Australian regulation, operating costs, or additional redeployments could signal how flexible Carnival is willing to be with its global footprint compared with peers. You can also track whether new entertainment formats and route shifts are mentioned in future guidance updates or earnings commentary as contributors to onboard yield and capacity plans.</p> <p>To ensure you're always in the loop on how the latest news impacts the investment narrative for Carnival Corporation &amp;, head to the\n                        <a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/CCL\" rel=\"noopener noreferrer\" target=\"_blank\">community page for Carnival Corporation &amp;</a> to never miss an update on the top community narratives.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-28 08:16:01",
            "link": "https://simplywall.st/stocks/us/consumer-services/nyse-ccl/carnival-corporation/news/carnival-millions-launch-and-ship-redeployment-reshape-onboa",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Metrovacesa (BME:MVC) Valuation Check After Strong Full Year Profit Rebound",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Metrovacesa earnings spark fresh interest in the stock</h2> <p>Metrovacesa (BME:MVC) has attracted fresh attention after reporting full year 2025 net income of ‚Ç¨56.86 million, compared with ‚Ç¨15.89 million a year earlier, alongside higher basic and diluted earnings per share from continuing operations.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/es/real-estate-management-and-development/bme-mvc/metrovacesa-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Metrovacesa.</a></p> <p>The earnings release comes after a strong run in the shares, with a 30-day share price return of 30.26% and a 38.89% year to date share price return. The 5-year total shareholder return of 285.18% points to momentum that has built over time.</p> <p>If Metrovacesa‚Äôs move has caught your eye, it could be a good moment to broaden your search and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_founder_led\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/global\" rel=\"noopener noreferrer\" target=\"_blank\">96 top founder-led companies</a> as potential next ideas.</p> <p>With net income at ‚Ç¨56.86 million, earnings per share at ‚Ç¨0.38 and the share price up 38.89% year to date, is Metrovacesa still undervalued, or is the market already pricing in future growth?</p> <h2>Most Popular Narrative: 0.8% Undervalued</h2> <p>The most followed valuation narrative puts Metrovacesa‚Äôs fair value at ‚Ç¨13.10, just above the ‚Ç¨13.00 last close, which keeps the focus firmly on the details behind that estimate.</p> <blockquote> <p><em>Metrovacesa's dedicated investment in delivering only AA energy efficiency buildings surpassing regulatory standards positions the company to capture premium pricing, secure cheaper green financing, and establish clear leadership as sustainability becomes the decisive factor in real estate demand, supporting higher margins and asset valuations.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/l4qmrxqy-urbanization-and-green-building-will-drive-lasting-value\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Want to see what is baked into that ‚Ç¨13.10 fair value? The narrative leans on rising margins, steadier cash generation and a richer earnings multiple. The exact mix of growth, profitability and discount rate assumptions might surprise you.</p> <p><strong>Result: Fair Value of ‚Ç¨13.10 (UNDERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/l4qmrxqy-urbanization-and-green-building-will-drive-lasting-value\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, you also need to weigh risks, such as weaker housing demand in Spain or higher construction and compliance costs that could squeeze future margins and cash generation.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/es/real-estate-management-and-development/bme-mvc/metrovacesa-shares\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Metrovacesa narrative.</a></p> <h2>Another View: Pricing Looks Full On Earnings</h2> <p>The fair value narrative suggests Metrovacesa is only 0.8% undervalued at ‚Ç¨13.10, close to the ‚Ç¨13.00 share price. But on earnings, the picture is less relaxed, with a P/E of 34.7x versus a fair ratio of 12.2x, the European real estate average of 13.5x and a 14.5x peer average.</p> <p>That gap means the market is already paying a high price for each euro of current earnings, so any disappointment or reset in expectations could matter more than usual. Does that premium match your own view of the company‚Äôs future, or does it make you more cautious about what is already priced in?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/es/real-estate-management-and-development/bme-mvc/metrovacesa-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/es/real-estate-management-and-development/bme-mvc/metrovacesa-shares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"BME:MVC P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/91490c3e-a80b-4ae8-9554-84421457f827/chart/pe-multiple-vs-industry?date=2026-02-27\" width=\"746\"/></a><figcaption>BME:MVC P/E Ratio as at Feb 2026</figcaption></figure><p> </p><h2>Next Steps</h2> <p>With the mixed signals on value and expectations, do you feel the market is being too cautious or too optimistic? Take a moment to review the full picture for yourself and weigh both sides of the story with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/es/real-estate-management-and-development/bme-mvc/metrovacesa-shares\" rel=\"noopener noreferrer\" target=\"_blank\">2 key rewards and 2 important warning signs</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If this earnings story has sharpened your focus, do not stop here. Widening your watchlist now could be the edge you regret skipping later.</p> <ul> <li>Spot potential mispricings early by scanning our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">225 high quality undervalued stocks</a> that pair solid fundamentals with more modest expectations.</li> <li>Strengthen your income stream by reviewing <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_dividend\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/global\" rel=\"noopener noreferrer\" target=\"_blank\">447 dividend fortresses</a> that combine 5%+ yields with an emphasis on staying power.</li> <li>Protect your downside by checking <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/global\" rel=\"noopener noreferrer\" target=\"_blank\">329 resilient stocks with low risk scores</a> that screen for resilient balance sheets and lower overall risk scores.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-28 08:16:01",
            "link": "https://simplywall.st/stocks/es/real-estate-management-and-development/bme-mvc/metrovacesa-shares/news/metrovacesa-bmemvc-valuation-check-after-strong-full-year-pr",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "PACS Group ESOP Shelf Spurs Questions On Dilution And Staff Alignment",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>PACS Group (NYSE:PACS) has filed a large shelf registration tied to an employee stock ownership plan related common stock offering.</li> <li>The filing outlines a framework for issuing a substantial amount of common shares to support ESOP activity over time.</li> <li>This move is designed to connect employee compensation more directly with the company‚Äôs equity.</li> </ul> <p>PACS Group operates in the post acute care and senior living space, where staffing, retention, and alignment of incentives are central issues for operators and investors. An ESOP related shelf registration is directly related to that discussion, since equity based incentives can be a key part of how healthcare providers seek to retain and motivate staff. For shareholders, the filing is a structural update that sits alongside broader industry attention on workforce stability and care quality.</p> <p>For investors, key considerations include how much stock might eventually be issued under this shelf, over what timeframe, and on what terms employees gain access. The filing establishes a framework rather than an immediate transaction, so the specifics of future issuances, potential dilution, and any capital raising that may be associated with ESOP funding could be important to monitor as PACS Group develops this plan.</p> <p>Stay updated on the most important news stories for <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">PACS Group</a> by adding it to your <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>. Alternatively, explore our <a class=\"company-report-links\" data-vars-link-type=\"news_stay_updated_cta\" href=\"https://simplywall.st/stock/NYSE/PACS\" rel=\"noopener noreferrer\" target=\"_blank\">Community</a> to discover new perspectives on PACS Group.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/healthcare/nyse-pacs/pacs-group\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:PACS 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/c88f10aa-2a97-4cf5-939c-761db77b0ad6/chart/quote-price?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:PACS 1-Year Stock Price Chart</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_news_ownership\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/ownership\" rel=\"noopener noreferrer\" target=\"_blank\">See which insiders are buying and buying and selling PACS Group following this latest news.</a></p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Investor Checklist: ESOP Shelf Registration and What It Means for PACS Group</h2> <h3>Quick Assessment</h3> <ul> <li><strong>‚öñÔ∏è Price vs Analyst Target</strong>: At US$41.67, PACS Group trades about 6% below the US$44.20 analyst price target range midpoint.</li> <li><strong>‚ùå Simply Wall St Valuation</strong>: The shares are described as trading at a very large premium to the estimated fair value.</li> <li><strong>‚úÖ Recent Momentum</strong>: The 30 day return of about 21.2% shows strong short term price strength.</li> </ul> <p>There is only one way to know the right time to buy, sell or hold PACS Group. Head to Simply Wall St's\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">company report for the latest analysis of PACS Group's Fair Value</a>.</p> <h3>Key Considerations</h3> <ul> <li>üìä The ESOP shelf creates capacity to issue more shares over time. This can align employees with shareholders but may also increase dilution if fully used.</li> <li>üìä Watch how many shares are actually issued under the ESOP, the pace of issuance, and any commentary on how it ties into retention in skilled nursing and assisted living operations.</li> <li>‚ö†Ô∏è Given the current premium to estimated fair value, investors may want to track whether ESOP related issuance adds to the share count at today‚Äôs valuation levels.</li> </ul> <h3>Dig Deeper</h3> <p>For the full picture including more risks and rewards, check out the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group\" rel=\"noopener noreferrer\" target=\"_blank\">complete PACS Group analysis</a>. Alternatively, you can visit the\n<a class=\"company-report-links\" href=\"https://www.simplywall.st/stock/NYSE/PACS\" rel=\"noopener noreferrer\" target=\"_blank\">community page for PACS Group</a> to see how other investors believe this latest news will impact the company's narrative.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-28 08:06:45",
            "link": "https://simplywall.st/stocks/us/healthcare/nyse-pacs/pacs-group/news/pacs-group-esop-shelf-spurs-questions-on-dilution-and-staff",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Innoviva (INVA) One Off Gain Driven 65.9% Margin Challenges Bullish Earnings Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Innoviva (INVA) has wrapped up FY 2025 with Q4 revenue of US$114.6 million and basic EPS of US$2.19, capping a trailing 12 month period where revenue was US$411.3 million and basic EPS reached US$4.02 alongside a reported net profit margin of 65.9% that was lifted by a US$161.6 million one off gain. Over the past few quarters, the company has seen revenue move from US$88.6 million in Q1 2025 to US$114.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.74 in Q1 2025 to US$2.19 in Q4 2025. This sets up a results season in which investors are likely to focus on how durable these margins are.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Innoviva.</a> <p>With the headline numbers on the table, the next step is to see how they line up with the widely held narratives about Innoviva, and where the recent margin profile might challenge those views.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:INVA Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/66ba617d-8531-412c-a56b-bb0ac0cd97a5/chart/earnings-and-revenue-history?date=2026-02-27\" width=\"746\"/></a><figcaption>NasdaqGS:INVA Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Q4 profit swings from Q1 loss to US$164.2 million</h2> <ul> <li>Across FY 2025, net income moved from a loss of US$46.6 million in Q1 to US$164.2 million in Q4, with the trailing 12 month net income at US$271.2 million, so the full year picture is very different from how the year started.</li> <li>What stands out for a bullish take is how the trailing 12 month basic EPS reached US$4.02 and net profit margin was reported at 65.9%, yet this sits next to a five year annualised earnings decline of 22.1%. This means:\n    <ul> <li>Supporters who focus on the recent turnaround can point to Q2 to Q4 basic EPS between roughly US$1.01 and US$2.19 as evidence that profitability has held above early 2024 levels in recent quarters.</li> <li>The longer term decline in earnings growth rate, despite the strong trailing 12 month print, shows the bullish story is relying heavily on the latest year rather than a multi year pattern.</li> </ul> </li> </ul> <p>Strong recent profits sit next to a weaker multi year track record, and that tension is exactly what many investors are trying to weigh up right now. <a class=\"company-report-links\" data-vars-link-type=\"cta_consensus_narrative_link\" href=\"https://simplywall.st/stock/NasdaqGS/INVA\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üìä Read the what the Community is saying about Innoviva.</strong></a></p> <h2>One off gain inflates 65.9% margin</h2> <ul> <li>The reported 65.9% trailing net profit margin is much higher than the 6.5% margin a year earlier, and the data attributes a US$161.6 million one off gain as a key factor, so a large slice of the margin is tied to a single item rather than repeatable operations.</li> <li>Critics highlight that the very large year over year earnings improvement, described as more than a tenfold jump, is hard to treat as a new normal when:\n    <ul> <li>The one off gain of US$161.6 million fed directly into the trailing 12 month net income of US$271.2 million, which means a material portion of that profit is non recurring.</li> <li>The same data set shows analysts expecting earnings to decline by about 0.8% per year over the next three years, so the bearish view is that the spike in margins does not line up with the more muted outlook.</li> </ul> </li> </ul> <h2>‚ÄúCheap‚Äù 6.5x P/E versus 19.9x industry</h2> <ul> <li>At a share price of US$23.54, the trailing P/E of 6.5x sits well below both the reported US Pharmaceuticals industry average of 19.9x and a peer average of 17.7x, while the DCF fair value cited for Innoviva is US$53.96, which is much higher than the current price.</li> <li>What is interesting for the more cautious, bearish narrative is that this discount exists alongside softer longer term earnings trends and forecasts:\n    <ul> <li>Earnings across the last five years declined at about 22.1% per year, even though the most recent trailing 12 month period shows very strong profit, so the low P/E is being judged on a high earnings base that includes a large one off gain.</li> <li>Revenue is forecast to grow at 9.5% per year, slightly below the 10.4% reference rate for the US market, which bears use to argue that the apparent valuation gap may be partly explained by more modest growth expectations.</li> </ul> </li> </ul> <p>If you want to see how other investors are weighing that low 6.5x P/E against the earnings record and forecasts, the community discussion is a helpful next step. <a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <h2>Next Steps</h2> <p>Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Innoviva's <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/past\" rel=\"noopener noreferrer\" target=\"_blank\">growth</a> and its <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation</a> to see if today's price is a bargain. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> now so you don't miss the next big move.</p> <p>If the mixed signals in this story have you on the fence, it is worth checking the numbers yourself and forming a clear view quickly. You can weigh the tension between concerns and optimism by looking at <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 3 important warning signs</a> for this company and seeing which side of the story matters more to you.</p> <h2>See What Else Is Out There</h2> <p>Innoviva‚Äôs reliance on a one off US$161.6 million gain, a five year annualised earnings decline of 22.1%, and softer forecasts raises questions about consistency.</p> <p>If that patchy earnings record has you looking for steadier stories, check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> today to focus on companies with more resilient profiles.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-28 08:06:45",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inva/innoviva/news/innoviva-inva-one-off-gain-driven-659-margin-challenges-bull",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Assessing Savara (SVRA) Valuation After FDA Priority Review For MOLBREEVI",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Savara (SVRA) is back in focus after the FDA accepted for review the biologics license application for MOLBREEVI to treat autoimmune pulmonary alveolar proteinosis and granted it Priority Review with an August 22, 2026 action date.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Savara.</a></p> <p>The FDA news arrives after a mixed few months for Savara, with a 1-day share price return of 2.23% and a 7-day share price return of 4.37%. However, the 90-day share price return shows a 5.09% decline, which contrasts with a 1-year total shareholder return of 142.68%. This indicates that long-term momentum remains intact even as shorter-term sentiment has been choppy.</p> <p>If this kind of regulatory milestone has caught your attention, it could be a good moment to broaden your watchlist and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_healthcare_ai\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/us\" rel=\"noopener noreferrer\" target=\"_blank\">29 healthcare AI stocks</a> as another source of potential ideas.</p> <p>With Savara still loss making and trading at US$5.97 against an average analyst price target of US$10.81, you have to ask: is there genuine upside here, or is the market already pricing in future growth?</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Preferred Price-to-Book Multiple of 15.6x: Is it justified?</h2> <p>On a simple yardstick, Savara‚Äôs current P/B of 15.6x sets a high bar, especially with the company still loss making and generating less than $1m in revenue.</p> <p>P/B compares the market value of the company to the book value of its net assets, so a higher multiple usually reflects strong expectations for future value creation rather than current profitability.</p> <p>Here, the disconnect is clear: earnings are negative, losses have grown at around 20.3% per year over the past 5 years, and there is no meaningful current revenue. Yet the market is assigning a premium that suggests investors are heavily focused on future growth potential and the aPAP opportunity rather than today‚Äôs financials.</p> <p>That premium also stands out against peers. Savara‚Äôs 15.6x P/B is described as expensive versus both the US Biotechs industry average of 2.7x and a peer average of 12.1x, implying the market is paying a significantly richer multiple than is typical for the space.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p><strong>Result: Price-to-book of 15.6x (OVERVALUED)</strong></p> <p>However, you still have to weigh the risk that the company remains loss making, with net income of $115.645m in the red and no current revenue base.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Savara narrative.</a></p> <h2>Next Steps</h2> <p>With sentiment clearly split between the risks and the potential upside, it makes sense to act now and review the numbers for yourself, starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 1 important warning sign</a>.</p> <h2>Looking for more investment ideas?</h2> <p>If you are serious about sharpening your watchlist, do not stop at one stock story, use the Simply Wall St screener to uncover ideas you might otherwise miss.</p> <ul> <li>Spot potential value opportunities early by scanning companies on our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">54 high quality undervalued stocks</a> list that pair quality fundamentals with prices that may not fully reflect them.</li> <li>Strengthen your defensive side by reviewing companies in the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">80 resilient stocks with low risk scores</a> that score well on stability and downside protection.</li> <li>Get ahead of the crowd by checking the <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 24 high quality undiscovered gems</a> where strong fundamentals have yet to attract broad attention.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-28 08:06:45",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-svra/savara/news/assessing-savara-svra-valuation-after-fda-priority-review-fo",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Ahold Delhaize (ENXTAM:AD) Margin Improvement And 28% EPS Growth Test Cautious Growth Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Koninklijke Ahold Delhaize (ENXTAM:AD) has wrapped up FY 2025 with fourth quarter revenue of ‚Ç¨23.5b and basic EPS of ‚Ç¨0.65, while trailing twelve month EPS sits at ‚Ç¨2.51 on revenue of ‚Ç¨92.4b, with earnings over the past year growing 28.3% and net profit margin at 2.5% versus 2.0% a year earlier. Over recent quarters, the company has seen quarterly revenue range between ‚Ç¨22.0b and ‚Ç¨23.5b with basic EPS between ‚Ç¨0.60 and ‚Ç¨0.65. This sets up investors to focus on how this earnings momentum, margin improvement and trailing year growth potential line up against the company‚Äôs long term story.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/nl/consumer-retailing/ams-ad/koninklijke-ahold-delhaize-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Koninklijke Ahold Delhaize.</a> <p>With the headline numbers on the table, the next step is to see how these results square with the widely held narratives around Ahold Delhaize‚Äôs growth, risks and long term earnings power, and where the latest figures may challenge those views.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/nzlb4xbk-demographic-shifts-and-digital-expansion-will-create-lasting-value-sdn5\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Koninklijke Ahold Delhaize</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/nl/consumer-retailing/ams-ad/koninklijke-ahold-delhaize-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ENXTAM:AD Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/93f3f488-6688-430e-ab7c-67148656f7bd/chart/revenue-and-expenses-breakdown?date=2026-02-27\" width=\"746\"/></a><figcaption>ENXTAM:AD Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Trailing EPS and margins step up against 5 year trend</h2> <ul> <li>On a trailing basis, EPS is ‚Ç¨2.51 on ‚Ç¨92.4b of revenue with net income of ‚Ç¨2.3b and a 2.5% net margin versus 2.0% a year earlier. That 28.3% earnings growth compares to a 5 year compound rate of 3.3%.</li> <li>Bulls argue that this kind of earnings acceleration supports a stronger long term story, yet the data creates a mixed picture:\n    <ul> <li>The 28.3% trailing earnings growth and higher 2.5% margin line up with the bullish view that better efficiency and mix can support higher profitability over time.</li> <li>At the same time, consensus and bullish scenarios are still only assuming earnings growth in the low to mid single digits each year, which is much closer to the older 3.3% 5 year trend than to the most recent year.</li> </ul> </li> </ul> Over the past year, that gap between the one year surge and the slower 5 year pace is exactly what bullish investors are debating in their forecasts for Ahold Delhaize, and it is unpacked further in the <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/nzlb4xbk-demographic-shifts-and-digital-expansion-will-create-lasting-value-sdn5\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Koninklijke Ahold Delhaize Bull Case</strong></a>. <h2>Steady quarterly EPS with same store sales around 3%</h2> <ul> <li>Across FY 2025, quarterly EPS stayed in a tight band between ‚Ç¨0.60 and ‚Ç¨0.65 while reported same store sales growth was 3.3% in Q1, 4.0% in Q2, 2.9% in Q3 and 3.2% on a trailing twelve month basis.</li> <li>Bears point out that this kind of mid single digit same store sales and stable EPS ties in with their concern about limited top line momentum:\n    <ul> <li>Forecasts for revenue growth of about 2.3% a year and earnings growth of about 4.4% a year are not far from what this same store sales range suggests and are slower than the Dutch market forecasts of 9.6% for revenue and 12.4% for earnings.</li> <li>This helps the bearish side argue that even with stable quarterly EPS today, future growth may be constrained by mature markets and rising competition in areas like online grocery and discount formats.</li> </ul> </li> </ul> Skeptical investors who see those growth forecasts as a ceiling rather than a floor are building their case around this slower profile, and you can see that laid out clearly in the <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/89uf5o5x-digital-competition-will-erode-market-share-and-raise-costs-6h5d\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Koninklijke Ahold Delhaize Bear Case</strong></a>. <h2>Valuation gap and slower growth vs Dutch market</h2> <ul> <li>The shares trade on a P/E of 16.4x versus a peer average of 28.1x and an industry average of 18.8x. A DCF fair value of ‚Ç¨57.98 sits above the current share price of ‚Ç¨41.77, even as revenue and earnings are forecast to grow at 2.3% and 4.4% a year compared with Dutch market forecasts of 9.6% and 12.4%.</li> <li>Consensus narrative tries to balance that discount with the more modest growth profile:\n    <ul> <li>On one side, the lower P/E relative to peers and the DCF fair value that is higher than the share price support the idea that investors are paying less for each euro of trailing earnings.</li> <li>On the other, flagged risks like an unstable dividend history, recent insider selling over the last three months and slower expected growth than the broader Dutch market give a straightforward reason why some investors may be cautious despite those valuation signals.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/nzlb4xbk-demographic-shifts-and-digital-expansion-will-create-lasting-value-sdn5\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Koninklijke Ahold Delhaize on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>Mixed messages in the data or a clear signal taking shape? If you want to move quickly and form your own view, it is worth weighing both the concerns and the bright spots that other investors are watching by checking out <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/nl/consumer-retailing/ams-ad/koninklijke-ahold-delhaize-shares\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>Ahold Delhaize faces slower forecast revenue and earnings growth than the wider Dutch market, alongside concerns around dividend stability and recent insider selling.</p> <p>If that combination of softer growth expectations and caution flags feels limiting, you may want to balance your portfolio with <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/global\" rel=\"noopener noreferrer\" target=\"_blank\">329 resilient stocks with low risk scores</a> that aim to keep risk in check while you assess your next move.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Koninklijke Ahold Delhaize might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/nl/consumer-retailing/ams-ad/koninklijke-ahold-delhaize-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 08:06:44",
            "link": "https://simplywall.st/stocks/nl/consumer-retailing/ams-ad/koninklijke-ahold-delhaize-shares/news/ahold-delhaize-enxtamad-margin-improvement-and-28-eps-growth",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Qt Group Oyj Q4 Margin Compression Tests Bullish Growth Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Qt Group Oyj (HLSE:QTCOM) has wrapped up FY 2025 with fourth quarter revenue of ‚Ç¨77.1 million, basic EPS of ‚Ç¨0.73 and net income of ‚Ç¨18.7 million, setting the tone for how the full year will be read by investors. The company has seen quarterly revenue move from ‚Ç¨68.5 million and EPS of ‚Ç¨1.13 in Q4 2024 to ‚Ç¨77.1 million and ‚Ç¨0.73 in Q4 2025, while the trailing twelve month EPS sits at ‚Ç¨1.25 on revenue of ‚Ç¨216.8 million. With revenue growth forecasts around 9.1% per year and earnings growth around 19.2% per year, set against a backdrop of thinner margins versus last year, the market focus is likely to be on how sustainable profitability looks from here.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/fi/software/hel-qtcom/qt-group-oyj-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Qt Group Oyj.</a> <p>With the numbers on the table, the next step is to see how this earnings print lines up with the prevailing stories around Qt Group Oyj, including expectations for growth, margins and risk over the longer term.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/sinqgcaq-qt-group-oyjs-somewhat-overvalued-but-with-a-potential-for-extra-dividends\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Qt Group Oyj</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/fi/software/hel-qtcom/qt-group-oyj-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"HLSE:QTCOM Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/a272a1bd-7a06-4ed5-b410-54a07479d5e8/chart/earnings-and-revenue-history?date=2026-02-27\" width=\"746\"/></a><figcaption>HLSE:QTCOM Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Margins Tighten As Net Profit Nearly Halves Year On Year</h2> <ul> <li>Trailing 12 month net income is ‚Ç¨31.8 million on ‚Ç¨216.8 million of revenue, giving a 14.7% net margin compared with 27.4% a year earlier on ‚Ç¨57.3 million of net income and ‚Ç¨209.1 million of revenue.</li> <li>Bears argue that pressure on deal sizes and contract lengths could keep profitability under strain, and the margin picture here lines up with that concern, as:\n    <ul> <li>Net income over the last 12 months is ‚Ç¨31.8 million versus ‚Ç¨54.7 million a year earlier on broadly similar trailing revenue levels of ‚Ç¨216.8 million and ‚Ç¨211.2 million.</li> <li>Q4 2025 net income of ‚Ç¨18.7 million on ‚Ç¨77.1 million of revenue contrasts with Q4 2024 net income of ‚Ç¨28.6 million on ‚Ç¨68.5 million of revenue, showing that higher quarterly sales have not translated into higher profits.</li> </ul> </li> </ul> Stay curious about how margin pressure fits into the cautious thesis that some investors have around Qt Group Oyj‚Äôs growth story. <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/5amot39l-update-for-qt-group-oyj\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Qt Group Oyj Bear Case</strong></a> <h2>Earnings Forecasts Outrun The Market While TTM Profits Reset Lower</h2> <ul> <li>Analysts forecast earnings growth of about 19.2% per year and revenue growth of roughly 9.1% per year, while trailing 12 month EPS is ‚Ç¨1.25 and net income is ‚Ç¨31.8 million compared with ‚Ç¨57.3 million a year earlier on similar revenue.</li> <li>Supporters of the bullish view point to those higher forecast growth rates as a key reason to stay focused on the longer term, yet the current earnings base is slimmer, because:\n    <ul> <li>Revenue on a trailing basis has moved from ‚Ç¨209.1 million to ‚Ç¨216.8 million, but trailing net income has moved from ‚Ç¨57.3 million to ‚Ç¨31.8 million, so future growth would be coming off a lower profit level.</li> <li>Quarterly EPS across FY 2025, at ‚Ç¨0.20, ‚Ç¨0.27, ‚Ç¨0.06 and ‚Ç¨0.73, is well below the trailing 12 month EPS figure from a year earlier of ‚Ç¨2.26, which frames how much rebuilding has to happen for those forecasts to play out.</li> </ul> </li> </ul> Bulls say the recent reset in profits could be the starting point for faster growth if the long term demand story plays out. <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/2vvs4mf7-embedded-software-shift-and-iar-integration-will-support-stronger-long-term-prospects\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Qt Group Oyj Bull Case</strong></a> <h2>Valuation Flags A Wide Gap To DCF Fair Value</h2> <ul> <li>At a share price of ‚Ç¨21.98, the stock is on a P/E of about 17.6x versus peer and industry averages of 37.5x and 23.8x. It also sits below the DCF fair value of ‚Ç¨52.74.</li> <li>What stands out for bullish investors is how this pricing compares with both forecasts and history, because:\n    <ul> <li>Forecast revenue growth of around 9.1% per year and earnings growth of about 19.2% per year are above the Finnish market forecasts of 4.1% and 13.1%, yet the P/E is lower than both peer and industry averages.</li> <li>The gap between the current ‚Ç¨21.98 share price and the ‚Ç¨52.74 DCF fair value from the data provides a large valuation cushion in the bullish story, set against the reality of a 14.7% trailing net margin and a high level of debt.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/sinqgcaq-qt-group-oyjs-somewhat-overvalued-but-with-a-potential-for-extra-dividends\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Qt Group Oyj on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With mixed signals on growth, margins and valuation, it is worth you looking at the underlying data yourself and forming a clear view. If you want a quick way to weigh both sides of the argument, take a look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/fi/software/hel-qtcom/qt-group-oyj-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 2 important warning signs</a> we have identified around this company.</p> <h2>Explore Alternatives</h2> <p>Qt Group Oyj‚Äôs thinner 14.7% net margin, lower trailing EPS and net income, and high debt level all point to pressure on profitability and balance sheet strength.</p> <p>If that mix of tighter margins and higher leverage feels uncomfortable, you may want to shift your attention toward companies in our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/global\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (374 results)</a> that aim for sturdier financial foundations and more resilient earnings power.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Qt Group Oyj might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/fi/software/hel-qtcom/qt-group-oyj-shares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 08:06:44",
            "link": "https://simplywall.st/stocks/fi/software/hel-qtcom/qt-group-oyj-shares/news/qt-group-oyj-q4-margin-compression-tests-bullish-growth-narr",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Truist Financial‚Äôs (TFC) M&A Hire and Bitcoin ETF Push Reframing Its Strategic Identity?",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Earlier this month, Truist Financial Corporation named veteran dealmaker Matthew Miller as managing director and head of mergers &amp; acquisitions, while also announcing plans to redeem US$1.25¬†billion of fixed-to-floating rate senior notes due March 2027 and expanding Truist Wealth‚Äôs lineup to include two SEC-registered spot bitcoin ETFs from Fidelity and BlackRock.</li> <li>Together, these moves highlight Truist‚Äôs effort to sharpen its advisory capabilities, refine its balance sheet, and cautiously broaden client access to digital assets within a regulated framework.</li> <li>We‚Äôll now examine how Truist‚Äôs enhanced M&amp;A leadership, alongside its evolving capital and product decisions, may reshape its investment narrative.</li> </ul><p>AI is about to change healthcare. These <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/us\" rel=\"noopener noreferrer\" target=\"_blank\">28 stocks are working on everything from early diagnostics to drug discovery</a>. The best part - they are all under $10b in market cap - there's still time to get in early.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Truist Financial Investment Narrative Recap</h2><p>To own Truist today, you need to be comfortable with a large regional bank that is balancing a traditional branch footprint, meaningful commercial real estate exposure, and ongoing post‚Äëmerger integration work against efforts to deepen fee income and advisory services. The latest announcements around M&amp;A leadership, debt redemption, and limited bitcoin ETF access do not materially change the near term focus on credit quality and expense discipline, or the risk that CRE and costs could weigh on margins.</p> <p>Among the recent moves, Truist‚Äôs decision to redeem US$1,250,000,000 of fixed‚Äëto‚Äëfloating senior notes due 2027 is most relevant, because it speaks directly to capital management at a time when investors are watching credit costs, branch related expenses, and the earnings impact of technology and talent spending. How Truist balances these capital decisions with its exposure to commercial real estate and continued investment in its physical network will likely shape sentiment around the stock‚Äôs key catalysts.</p> <p>Yet behind Truist‚Äôs efforts to fine tune its capital structure, investors should also be aware of the ongoing risk that its sizable commercial real estate exposure and large branch network could...</p> <p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/banks/nyse-tfc/truist-financial/6au6dvhx-tfc-operational-changes-and-discipline-in-profitability-will-drive-future-shareholder-returns\" rel=\"noopener noreferrer\" target=\"_blank\">Read the full narrative on Truist Financial (it's free!)</a></p><p>Truist Financial's narrative projects $22.5 billion revenue and $6.3 billion earnings by 2028. This requires 7.5% yearly revenue growth and a roughly $1.4 billion earnings increase from $4.9 billion today.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/banks/nyse-tfc/truist-financial/6au6dvhx-tfc-operational-changes-and-discipline-in-profitability-will-drive-future-shareholder-returns\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover how Truist Financial's forecasts yield a $57.11 fair value</a>, a 16% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/us/banks/nyse-tfc/truist-financial\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TFC 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/6b6ba9f4-42df-48a9-9ce3-42fb346a4dda/chart/quote-price\" width=\"746\"/></a><figcaption>TFC 1-Year Stock Price Chart</figcaption></figure> <p>Four members of the Simply Wall St Community currently estimate Truist‚Äôs fair value between US$37.76 and US$69.11, reflecting a wide spread of expectations. Against that backdrop, Truist‚Äôs efforts to refine its balance sheet and manage costs sit alongside persistent concerns about commercial real estate exposure and branch related expenses, which could meaningfully influence how those different valuation views play out over time.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/banks/nyse-tfc/truist-financial\" rel=\"noopener noreferrer\" target=\"_blank\">Explore 4 other fair value estimates on Truist Financial</a> - why the stock might be worth as much as 40% more than the current price!</p><h2>Reach Your Own Conclusion</h2><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p><ul><li>A great starting point for your Truist Financial research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/us/banks/nyse-tfc/truist-financial\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/us/banks/nyse-tfc/truist-financial\" rel=\"noopener noreferrer\" target=\"_blank\">Our free Truist Financial research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Truist Financial's overall financial health at a glance.</li></ul><h2>Searching For A Fresh Perspective?</h2><p>Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:</p><ul><li>Capitalize on the AI infrastructure supercycle with our selection of the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473744/ai-infrastructure-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">33 best 'picks and shovels' of the AI gold rush</a> converting record-breaking demand into massive cash flow.</li><li>Invest in the nuclear renaissance through our list of <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/473644/nuclear-renaissance/global\" rel=\"noopener noreferrer\" target=\"_blank\">84 elite nuclear energy infrastructure plays</a> powering the global AI revolution.</li><li>The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434414/ai-penny-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">22 smaller AI-focused companies with strong growth potential</a> through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Truist Financial might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/banks/nyse-tfc/truist-financial/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 08:01:34",
            "link": "https://simplywall.st/stocks/us/banks/nyse-tfc/truist-financial/news/is-truist-financials-tfc-ma-hire-and-bitcoin-etf-push-refram",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Aurinia Pharmaceuticals (AUPH) closed FY 2025 with Q4 revenue of US$77.1 million and basic EPS of US$1.60, alongside trailing twelve month EPS of US$2.14 on revenue of US$283.1 million. This frames a very strong headline earnings story. Over the past few quarters, the company has seen revenue move from US$59.9 million in Q4 2024 to US$77.1 million in Q4 2025, while quarterly EPS shifted from roughly breakeven at US$0.01 to US$1.60, with trailing twelve month net income reaching US$287.2 million. For investors, the key question now is how durable these higher profit margins are and what they imply for the quality of earnings going forward.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-auph/aurinia-pharmaceuticals\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Aurinia Pharmaceuticals.</a> <p>With the headline numbers set, the next step is to line these results up against the main narratives around Aurinia, highlighting where the recent margin profile backs the story and where it raises fresh questions.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/vvbvvgzz-increasing-pricing-pressures-and-limited-pipeline-will-weaken-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Aurinia Pharmaceuticals</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-auph/aurinia-pharmaceuticals/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGM:AUPH Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/69c169fb-65c3-4c5d-82a9-b2d6d505d821/chart/earnings-and-revenue-history?date=2026-02-27\" width=\"746\"/></a><figcaption>NasdaqGM:AUPH Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>TTM net income now slightly ahead of revenue</h2> <ul> <li>On a trailing twelve month basis, Aurinia reported net income of US$287.2 million on revenue of US$283.1 million, which means reported profit is slightly larger than sales over the same period.</li> <li>What stands out for the bullish narrative is how this very high reported profitability sits alongside claims of stronger LUPKYNIS adoption and cost discipline:\n    <ul> <li>Bulls point to three year efficacy data and updated treatment guidelines as drivers of revenue momentum. The trailing revenue line at US$283.1 million gives that story some support, even though part of the earnings jump is flagged as non cash.</li> <li>At the same time, the sharp step up from quarterly net income of US$1.4 million in Q4 2024 to US$210.8 million in Q4 2025 is so extreme that it invites the question of how much is repeatable operating profit versus one off or accounting driven items that bullish investors need to separate out.</li> </ul> </li> </ul> <p>Some investors see this earnings profile as the start of a stronger long term story, while others are more cautious about how much of it is sustainable.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/hc9reqtw-aging-demographics-and-lupkynis-uptake-will-expand-markets\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Aurinia Pharmaceuticals Bull Case</strong></a> <h2>Low 6.4x P/E versus high growth backdrop</h2> <ul> <li>The shares trade on a P/E of 6.4x against a current price of US$13.97, while revenue is described as forecast to grow about 11.7% per year and TTM EPS sits at US$2.14.</li> <li>Bears highlight that even this low multiple may be justified if the quality of those earnings is weaker than it looks and if profits ease back from here:\n    <ul> <li>The risk summary flags that a large portion of earnings is non cash, so the gap between US$287.2 million of TTM net income and the revenue line can challenge the idea that the stock simply looks cheap on headline EPS.</li> <li>Analyst models pointing to roughly 5.1% annual earnings declines over the next three years run against the very strong trailing profit picture, which supports the bearish view that the current 6.4x P/E might already be factoring in some of this pressure.</li> </ul> </li> </ul> <p>For you as an investor, the tension between a low P/E and earnings forecasts is where a lot of the debate is happening.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/vvbvvgzz-increasing-pricing-pressures-and-limited-pipeline-will-weaken-outlook\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Aurinia Pharmaceuticals Bear Case</strong></a> <h2>DCF fair value far above current price</h2> <ul> <li>The DCF fair value provided is US$41.93 per share versus the current share price of US$13.97, while the only allowed analyst price target reference here is US$16.67, so both reference points sit above where the stock trades today.</li> <li>Consensus narrative views this gap through the lens of both opportunities and risks, and the recent financials give you data for each side:\n    <ul> <li>On the opportunity side, analysts expect revenue to grow 14.1% per year with profit margins moving from 23.3% to 36.6%, and TTM margins are already described as 2.4 percentage points higher than a year ago. This lines up with a story of improving economics.</li> <li>On the risk side, the same consensus flags that earnings are expected to be around US$141.3 million by 2028, well below the current TTM net income of US$287.2 million. This signals that the recent profitability spike is not being treated as a permanent baseline in those models.</li> </ul> </li> </ul> <p>That mix of a higher DCF fair value and more cautious earnings forecasts is why it helps to separate one off strength from what you think Aurinia can produce year in, year out.</p> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/vvbvvgzz-increasing-pricing-pressures-and-limited-pipeline-will-weaken-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Aurinia Pharmaceuticals on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With both bullish and bearish cases on the table, this is the moment to review the numbers yourself and move quickly to shape your own view, starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-auph/aurinia-pharmaceuticals\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 2 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>The big question hanging over Aurinia is whether current earnings, which rely heavily on non cash items and sit above revenue, can really hold over time.</p> <p>If you want ideas where profits and cash flows may be more closely aligned, check out our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">77 resilient stocks with low risk scores</a> right now and compare how those companies handle earnings quality.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-28 08:01:33",
            "link": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-auph/aurinia-pharmaceuticals/news/aurinia-pharmaceuticals-auph-earnings-spike-above-revenue-ch",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Expanded M&A Firepower and Point72 Stake Could Be A Game Changer For TransDigm Group (TDG)",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>Recently, TransDigm Group outlined an aggressive acquisition program with three completed deals and nearly US$10.00¬†billion in remaining M&amp;A capacity, while also lifting full-year guidance on the back of an improved revenue outlook and robust defense segment performance.</li> <li>A further development was Steve Cohen‚Äôs Point72 Asset Management initiating a new US$336.00¬†million position in TransDigm, taking ownership to about 0.45% of the company‚Äôs shares outstanding and underscoring heightened institutional interest in its aircraft components business.</li> <li>Next, we‚Äôll examine how TransDigm‚Äôs expanded acquisition firepower could influence its established investment narrative around aftermarket cash flows.</li> </ul><p>We've uncovered the <a class=\"company-report-links\" data-vars-link-type=\"intro\" href=\"https://simplywall.st/discover/investing-ideas/473528/dividend-fortresses/us\" rel=\"noopener noreferrer\" target=\"_blank\">15 dividend fortresses</a> yielding 5%+ that don't just survive market storms, but thrive in them.</p><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>TransDigm Group Investment Narrative Recap</h2><p>To own TransDigm, you have to believe in the durability of its high margin aftermarket parts model and its ability to deploy capital effectively through cycles. The key near term catalyst is how well new acquisitions integrate into that aftermarket cash flow engine, while the biggest risk remains its leveraged balance sheet. The latest guidance raise and defense strength do not materially change that risk profile, but they may reinforce confidence in the underlying cash generation story.</p> <p>The most relevant development here is TransDigm‚Äôs declaration of nearly US$10.00 billion in remaining M&amp;A capacity after three recent deals. That level of ‚Äúacquisition firepower‚Äù directly ties into the company‚Äôs long running playbook of buying cash generative aerospace businesses to feed its aftermarket revenue base. It also interacts with leverage risk, because any sizeable dealmaking from this point is likely to be funded, at least in part, through additional borrowing.</p> <p>But while the acquisition story is compelling, investors should also be aware of how TransDigm‚Äôs already high leverage and interest costs could...</p> <p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/capital-goods/nyse-tdg/transdigm-group/f88hh54b-analysts-adjust-transdigm-group-outlook-amid-aftermarket-strength-and-softer-oem-demand\" rel=\"noopener noreferrer\" target=\"_blank\">Read the full narrative on TransDigm Group (it's free!)</a></p><p>TransDigm Group's narrative projects $10.8 billion revenue and $2.5 billion earnings by 2028. This requires 8.0% yearly revenue growth and about a $0.7 billion earnings increase from $1.8 billion today.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/capital-goods/nyse-tdg/transdigm-group/f88hh54b-analysts-adjust-transdigm-group-outlook-amid-aftermarket-strength-and-softer-oem-demand\" rel=\"noopener noreferrer\" target=\"_blank\">Uncover how TransDigm Group's forecasts yield a $1586 fair value</a>, a 22% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://simplywall.st/stocks/us/capital-goods/nyse-tdg/transdigm-group\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"TDG 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/1cd5c1ce-3774-4e27-b69c-24682a1a1e26/chart/quote-price\" width=\"746\"/></a><figcaption>TDG 1-Year Stock Price Chart</figcaption></figure> <p>Four members of the Simply Wall St Community value TransDigm between about US$1,121 and US$1,586 per share, highlighting a wide spread in expectations. When you set those views against TransDigm‚Äôs sizeable M&amp;A capacity and already stretched balance sheet, it underlines why different investors may weigh the company‚Äôs growth ambitions and leverage risk very differently.</p><p><a class=\"company-report-links\" data-vars-link-type=\"integrated-pitch\" href=\"https://simplywall.st/community/narratives/us/capital-goods/nyse-tdg/transdigm-group\" rel=\"noopener noreferrer\" target=\"_blank\">Explore 4 other fair value estimates on TransDigm Group</a> - why the stock might be worth as much as 22% more than the current price!</p><h2>The Verdict Is Yours</h2><p>Don't just follow the ticker - dig into the data and build a conviction that's truly your own.</p><ul><li>A great starting point for your TransDigm Group research is our analysis highlighting <a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/us/capital-goods/nyse-tdg/transdigm-group\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 4 important warning signs</a> that could impact your investment decision.</li><li><a class=\"company-report-links\" data-vars-link-type=\"conclusion\" href=\"https://simplywall.st/stocks/us/capital-goods/nyse-tdg/transdigm-group\" rel=\"noopener noreferrer\" target=\"_blank\">Our free TransDigm Group research report</a> provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate TransDigm Group's overall financial health at a glance.</li></ul><h2>Seeking Other Investments?</h2><p>Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:</p><ul><li>Uncover the next big thing with <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/472945/elite-penny-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">30 elite penny stocks</a> that balance risk and reward.</li><li>AI is about to change healthcare. These <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434426/healthcare-ai/us\" rel=\"noopener noreferrer\" target=\"_blank\">28 stocks are working on everything from early diagnostics to drug discovery</a>. The best part - they are all under $10b in market cap - there's still time to get in early.</li><li>Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the <a class=\"company-report-links\" data-vars-link-type=\"conclusion-grid\" href=\"https://simplywall.st/discover/investing-ideas/434418/rare-earth-metal-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">31 best rare earth metal stocks</a> of the very few that mine this essential strategic resource.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if TransDigm Group might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/capital-goods/nyse-tdg/transdigm-group/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 08:01:33",
            "link": "https://simplywall.st/stocks/us/capital-goods/nyse-tdg/transdigm-group/news/expanded-ma-firepower-and-point72-stake-could-be-a-game-chan",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Clipper Realty Q4 FFO Recovery Challenges Bearish Narratives On Cash Generation",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Clipper Realty FY 2025 results: revenue holds steady as losses persist</h2> <p>Clipper Realty (CLPR) has posted its FY 2025 results with Q4 revenue of US$37.1 million and basic EPS of a US$0.28 loss, while trailing 12 month revenue stands at US$153.2 million and EPS at a US$1.38 loss. Over recent quarters the company has seen quarterly revenue move in a tight band between US$37.1 million and US$39.4 million, as net income swung from a Q1 loss of US$13.9 million to a Q4 loss of US$2.5 million and funds from operations ranged from a Q1 loss of US$27.5 million to US$18.1 million in Q4. For investors, the picture is one of pressured margins and a thin cushion in the income statement, so a key consideration is whether the current run rate of revenue can eventually support more stable cash generation.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/real-estate/nyse-clpr/clipper-realty\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Clipper Realty.</a> <p>With the headline numbers on the table, the next step is to see how this earnings profile lines up with the widely held narratives about Clipper Realty, and where the data pushes back against those stories.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/real-estate/nyse-clpr/clipper-realty/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:CLPR Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/b87836a7-33be-4df8-918d-f08efabc3787/chart/earnings-and-revenue-history?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:CLPR Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <h2>FFO swings from US$27.5m loss to US$18.1m gain</h2> <ul> <li>Across FY 2025, Funds From Operations moved from a Q1 loss of US$27.5 million to a Q4 gain of US$18.1 million, with the trailing 12 month figure at Q3 still at a loss of US$11.6 million, so cash style earnings improved through the year but remain weak on a full year basis.</li> <li>Bears focus on the company being unprofitable with a 19.9% annual earnings decline over five years. The sharp Q1 to Q4 FFO move creates tension with that view by showing:\n    <ul> <li>Quarterly FFO in FY 2025 ranged from the US$27.5 million loss in Q1 to positive US$5.9 million in Q2 and US$18.1 million in Q4, which contrasts with the idea of a simple straight line decline.</li> <li>At the same time, trailing 12 month net income at Q4 remains a loss of US$19.9 million, so the bearish argument about weak profitability and capital structure still lines up with the full year picture.</li> </ul> </li> </ul> <h2>Negative equity and 12.01% yield keep risk high</h2> <ul> <li>Trailing data flag negative shareholders‚Äô equity alongside a 12.01% dividend yield that is not well covered by earnings, while the trailing 12 month net loss of US$19.9 million and EPS loss of US$1.38 underline that current income and capital structure remain under pressure.</li> <li>Critics highlight the major risks of a 19.9% annualized earnings decline over five years and weak dividend coverage, and the reported numbers echo that concern by showing:\n    <ul> <li>Losses across all four FY 2025 quarters, from US$13.9 million in Q1 to US$2.5 million in Q4, and trailing 12 month losses that have widened from US$3.98 million at FY 2024 Q4 to US$19.9 million at FY 2025 Q4.</li> <li>With negative equity already in place, those continuing losses are an important signal for investors who are weighing the sustainability of that 12.01% yield against balance sheet resilience.</li> </ul> </li> </ul> If you want to see how other investors balance that high yield against the balance sheet, <a class=\"company-report-links\" data-vars-link-type=\"cta_consensus_narrative_link\" href=\"https://simplywall.st/stock/NYSE/CLPR\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üìä Read the what the Community is saying about Clipper Realty.</strong></a> could help frame the trade off in a broader context.\n\n<h2>P/S of 0.3x and DCF fair value flag valuation gap</h2> <ul> <li>The shares trade on a P/S of 0.3x compared with 2.4x for peers and 5.2x for the North American Residential REITs industry, and the DCF fair value of US$6.65 versus a market price of US$3.17 implies the stock sits about 52.4% below that cash flow based estimate.</li> <li>More optimistic investors point to this apparent valuation gap as a key part of the bullish case, and the trailing data give them some support but also clear caveats:\n    <ul> <li>The low P/S multiple and the roughly 52.4% discount to the US$6.65 DCF fair value fit the idea that the market is heavily discounting the stock relative to its cash flow estimate.</li> <li>However, the same dataset notes the company is unprofitable with negative equity and a five year earnings decline of 19.9% per year, so anyone leaning on that valuation upside is effectively betting that these reported issues can eventually be addressed.</li> </ul> </li> </ul> <h2>Next Steps</h2> <p>Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Clipper Realty's <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/us/real-estate/nyse-clpr/clipper-realty/past\" rel=\"noopener noreferrer\" target=\"_blank\">growth</a> and its <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://www.simplywall.st/stocks/us/real-estate/nyse-clpr/clipper-realty/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation</a> to see if today's price is a bargain. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_dont_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> now so you don't miss the next big move.</p> <p>If this mix of pressures and potential leaves you on the fence, it is worth checking the numbers yourself and forming your own view quickly, including weighing <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/real-estate/nyse-clpr/clipper-realty\" rel=\"noopener noreferrer\" target=\"_blank\">1 key reward and 4 important warning signs</a>.</p> <h2>Explore Alternatives</h2> <p>Clipper Realty combines persistent losses, negative equity and a 12.01% yield that is not well covered, so the balance sheet risk is front and center.</p> <p>If that level of financial strain makes you uneasy, use our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (39 results)</a> to quickly focus on companies where fundamentals and leverage look more robust right now.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-28 08:01:33",
            "link": "https://simplywall.st/stocks/us/real-estate/nyse-clpr/clipper-realty/news/clipper-realty-q4-ffo-recovery-challenges-bearish-narratives",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Solventum (SOLV) One Off US$1.5b Gain Raises Questions For Bullish Margin Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Solventum (SOLV) has just wrapped up FY 2025 with Q4 revenue of US$1.998 billion, Basic EPS of US$0.36 and trailing twelve month EPS of US$8.94, alongside a very large one off gain that helped push earnings up 224.8% over the past year. Over the last few quarters the company has seen revenue move between US$2.070 billion and US$2.161 billion, while trailing twelve month net income excluding extra items has shifted from US$479 million in FY 2024 Q4 to US$1.56 billion in FY 2025 Q4. This leaves investors focused on how much of that uplift is flowing through to sustainable margins versus one time items.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-solv/solventum\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Solventum.</a> <p>With the headline numbers on the table, the next step is to see how these results line up against the prevailing narratives around Solventum, and where the margin story supports or challenges what investors have been assuming.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/iaj7bf3g-solv-portfolio-reshaping-and-cost-controls-will-improve-outlook-for-2025\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Solventum</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-solv/solventum/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:SOLV Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/862ea654-9363-4b78-b046-95aafa94571b/chart/earnings-and-revenue-history?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:SOLV Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Trailing US$1.6b profit, but heavily boosted by one off gain</h2> <ul> <li>Over the last 12 months, Solventum generated about US$8.3b of revenue and US$1.6b of net income excluding extra items, with that period also including a very large US$1.5b one off gain that inflates the headline profit story.</li> <li>What stands out for the bullish narrative is that this strong trailing net margin of 18.7% sits alongside a five year EPS trend that has declined about 8.5% a year, which means:\n    <ul> <li>Bulls pointing to current profitability and a DCF fair value of about US$149.45 need to factor in how much of the recent US$1.6b profit is repeatable once the US$1.5b gain is stripped out.</li> <li>At the same time, the bullish view that efficiency programs and portfolio changes can support higher quality earnings is not directly confirmed or disproved by these figures, since the data shows strong recent margins but also weaker multi year EPS.</li> </ul> </li> </ul> Have a look at how bullish investors connect these numbers to their long term story for Solventum: <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/qd1r9o06-update-for-solventum\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Solventum Bull Case</strong></a> <h2>Low 8.3x P/E and US$74.20 price versus US$149.45 DCF fair value</h2> <ul> <li>Solventum trades at about US$74.20 per share on a trailing P/E of 8.3x, compared with a DCF fair value estimate of roughly US$149.45 and peer and industry P/E averages around 33.5x and 30.9x respectively.</li> <li>Analysts' consensus view that the stock looks inexpensive on several measures meets some pushback from the fundamentals, because:\n    <ul> <li>The big gap between the current price and DCF fair value is based on earnings that include the US$1.5b one off gain, so any comparison that uses trailing profit is sensitive to that single event.</li> <li>Forecast revenue growth of about 1.1% a year and expected earnings growth of 5.32% a year are both below broader US market expectations, which is a different tone from the idea that the business is on a strong structural growth path.</li> </ul> </li> </ul> <h2>Interest coverage flagged as a major financial risk</h2> <ul> <li>Risk analysis highlights that interest payments are not well covered by earnings, even after a year in which reported earnings grew very sharply and trailing net margin reached 18.7%.</li> <li>Bears argue that this weak interest coverage, together with modest revenue forecasts, could limit how much the company benefits from cost savings and portfolio changes, because:\n    <ul> <li>Even with trailing twelve month net income of about US$1.6b, the fact that interest is still flagged as a major risk suggests a meaningful portion of that profitability is not easily available for debt service once you adjust for the US$1.5b gain.</li> <li>Bearish analysts also expect revenue to fall 1.9% a year and margins to narrow toward 4%, which, if they were to occur, would put even more pressure on interest coverage than the already cautious risk flag implies.</li> </ul> </li> </ul> Skeptical investors focus on these pressure points to build a much more cautious case around Solventum's outlook: <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/kjfk0l1t-update-for-solventum\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Solventum Bear Case</strong></a> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/iaj7bf3g-solv-portfolio-reshaping-and-cost-controls-will-improve-outlook-for-2025\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Solventum on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If this mix of strong margins, one off gains and balance sheet questions leaves you on the fence, take a moment to look through the full risk and reward picture for yourself. You can weigh both sides quickly by checking the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/healthcare/nyse-solv/solventum\" rel=\"noopener noreferrer\" target=\"_blank\">5 key rewards and 2 important warning signs</a> and seeing how they line up with your own view.</p> <h2>See What Else Is Out There</h2> <p>Between modest forecast revenue and earnings growth, a five year EPS trend that moves lower, and weak interest coverage, Solventum's story leaves some big question marks.</p> <p>If that mix of slower growth and balance sheet pressure feels uncomfortable, it is worth checking companies in our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/us\" rel=\"noopener noreferrer\" target=\"_blank\">77 resilient stocks with low risk scores</a> that aim to keep risk firmly in check.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-28 08:01:33",
            "link": "https://simplywall.st/stocks/us/healthcare/nyse-solv/solventum/news/solventum-solv-one-off-us15b-gain-raises-questions-for-bulli",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Fluidra (BME:FDR) Margin Recovery With 27.5% Earnings Growth Tests Premium P/E Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Fluidra (BME:FDR) has wrapped up FY 2025 with fourth quarter revenue of ‚Ç¨524.2 million and net income of ‚Ç¨13.0 million. This capped a year in which trailing twelve month revenue reached ‚Ç¨2.2 billion and net income came in at ‚Ç¨176.0 million, supported by EPS of ‚Ç¨0.93. The company has seen quarterly revenue range from ‚Ç¨466.0 million to ‚Ç¨694.0 million across 2025, with net income moving between ‚Ç¨13.0 million and ‚Ç¨69.5 million. Over the last year, trailing net profit margin sat at 7.8% compared with 6.4% a year earlier, alongside earnings growth of 27.5%. For investors, that combination of higher earnings and firmer margins puts the focus on how sustainable this profitability profile looks from here.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/es/capital-goods/bme-fdr/fluidra-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Fluidra.</a> <p>With the headline numbers on the table, the next step is to see how these results line up with the most common narratives around Fluidra, highlighting where the data supports the story and where it starts to push back.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/se68f97l-home-improvement-demand-and-aftermarket-opportunities-will-redefine-industry-dynamics-9ut8\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Fluidra</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/es/capital-goods/bme-fdr/fluidra-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"BME:FDR Earnings &amp; Revenue History as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/f8443a7a-33d9-404e-82b8-1c5cc65acafc/chart/earnings-and-revenue-history?date=2026-02-27\" width=\"746\"/></a><figcaption>BME:FDR Earnings &amp; Revenue History as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>27.5% earnings growth with 7.8% margin</h2> <ul> <li>On a trailing twelve month basis, Fluidra earned ‚Ç¨176.0 million on ‚Ç¨2.2b of revenue, which works out to a 7.8% net margin and 27.5% earnings growth over the past year compared with the earlier 6.4% margin.</li> <li>Consensus narrative talks about aftermarket strength and a ‚Ç¨100 million cost simplification program supporting higher margins, and the data partly backs that up but also shows limits:\n    <ul> <li>Year to date, management has highlighted a 24% adjusted EBITDA margin and higher gross margin than 2024, which lines up with the move from a 6.4% to 7.8% net margin.</li> <li>At the same time, revenue growth referenced at about 4.7% a year is only slightly ahead of recent trailing trends, so the margin story is doing more of the heavy lifting than the top line.</li> </ul> </li> </ul> <h2>Quarterly swings behind the full year</h2> <ul> <li>Within FY 2025, quarterly revenue moved between ‚Ç¨466.0 million and ‚Ç¨694.0 million, while quarterly net income ranged from ‚Ç¨13.0 million to ‚Ç¨69.5 million, showing that the annual 7.8% margin is built on very different seasonal quarters.</li> <li>Bears argue that dependence on pricing, aftermarket demand and longer commercial project cycles could pressure volumes and margins, and the quarterly pattern highlights why they care about that:\n    <ul> <li>Q2 2025, with ‚Ç¨694.0 million of revenue and ‚Ç¨69.5 million of net income, sits well above Q3‚Äôs ‚Ç¨466.0 million revenue and ‚Ç¨27.5 million net income, which leaves less room if pricing or project timing turn less favorable.</li> <li>Bears also point to higher exposure to commercial pool projects and ongoing spending on digitalization and M&amp;A, so any quarter that looks closer to Q4‚Äôs ‚Ç¨13.0 million net income would quickly test how resilient that cost base really is.</li> </ul> </li> </ul> If you want to see how more cautious investors frame those swings against their longer term assumptions, check out the full bear-case breakdown for Fluidra: <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/dhyl3ma4-update-for-fluidra\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Fluidra Bear Case</strong></a> <h2>Premium P/E with high debt</h2> <ul> <li>Fluidra trades on a P/E of 24.5x versus peers at 17.8x and the wider European Machinery industry at 21.1x, while a DCF fair value of ‚Ç¨30.46 sits above the current ‚Ç¨22.68 share price and the business is flagged for high debt and an unstable dividend record.</li> <li>That mix of a premium P/E and DCF gap is at the heart of the more optimistic narrative, and the numbers cut both ways for bulls:\n    <ul> <li>The 27.5% trailing earnings growth and margin move to 7.8% support the bullish view that the current ‚Ç¨22.68 price could be below DCF fair value of ‚Ç¨30.46 if those trends are repeatable.</li> <li>On the other hand, the premium 24.5x P/E versus the 17.8x peer average, slower expected revenue growth of about 4.7% compared with a 5.8% Spanish market forecast, and the flagged high debt position all give investors concrete reasons to question how much of that DCF upside they want to pay for today.</li> </ul> </li> </ul> If you are weighing that premium P/E against the margin and earnings profile, it helps to see how bullish investors connect the dots across cycles in one place: <a href=\"?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ Fluidra Bull Case</strong></a> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/se68f97l-home-improvement-demand-and-aftermarket-opportunities-will-redefine-industry-dynamics-9ut8\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Fluidra on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>With both the upbeat and cautious angles laid out, how does Fluidra look to you right now? Take a moment to review the numbers, weigh the trade offs for yourself, and use our breakdown of <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/es/capital-goods/bme-fdr/fluidra-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 2 important warning signs</a> to see how that balance of concerns and potential upsides fits your own view.</p> <h2>Explore Alternatives</h2> <p>Fluidra combines a premium 24.5x P/E, high debt and an unstable dividend record, which may leave some investors uneasy about its overall risk profile.</p> <p>If that mix of leverage and payout uncertainty feels a bit too tight for comfort right now, check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_low_risk\" href=\"https://simplywall.st/discover/investing-ideas/473631/low-risk-leaders/global\" rel=\"noopener noreferrer\" target=\"_blank\">329 resilient stocks with low risk scores</a> to quickly find companies with more resilient, lower risk setups that could suit a steadier portfolio core.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>AI Stock Screener &amp; Alerts</h3><p>Our new AI Stock Screener scans the market every day to uncover opportunities.</p><p>‚Ä¢ Dividend Powerhouses (3%+ Yield)<br/>‚Ä¢ Undervalued Small Caps with Insider Buying<br/>‚Ä¢ High growth Tech and AI Companies<br/><br/>Or build your own from over 50 metrics.</p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/stock-screener\" target=\"_blank\">Explore Now for Free</a></div></div>",
            "pub_date": "2026-02-28 07:56:30",
            "link": "https://simplywall.st/stocks/es/capital-goods/bme-fdr/fluidra-shares/news/fluidra-bmefdr-margin-recovery-with-275-earnings-growth-test",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Is Huntington Bancshares (HBAN) Pricing Look Attractive After Recent Regional Bank Headlines",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><ul> <li>If you are wondering whether Huntington Bancshares is attractively priced at its current level, this article walks through what the numbers are really saying about the stock.</li> <li>The shares last closed at US$17.54, with a 7 day return of a 2.6% decline, a 30 day return of 2.8%, a year to date return of 0.3%, and a 1 year return of 10.6%, compared with 32.2% over 3 years and 34.9% over 5 years.</li> <li>Recent news coverage around regional banks has focused on how investors are weighing interest rate expectations, credit quality, and deposit trends, and Huntington Bancshares often features in that broader discussion. These themes help frame how the market is currently thinking about risk and reward for the stock.</li> <li>On our checks, Huntington Bancshares scores 2 out of 6 on valuation. You can see this in more detail in our <a class=\"company-report-links\" href=\"https://www.simplywall.st/stocks/us/banks/nasdaq-hban/huntington-bancshares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">valuation score</a>. Next we will look at what traditional methods like P/E, P/B and cash flow based models say about the share price, before finishing with a more complete way to think about value.</li> </ul> <p>Huntington Bancshares scores just 2/6 on our valuation checks. See what other red flags we found in the <a class=\"company-report-links\" data-vars-link-type=\"cta_low_value_score\" href=\"https://www.simplywall.st/stocks/us/banks/nasdaq-hban/huntington-bancshares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">full valuation breakdown</a>.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h3>Approach 1: Huntington Bancshares Excess Returns Analysis</h3> <p>The Excess Returns model looks at how much profit a bank can earn above the return that equity investors typically require, then capitalizes that stream of \"extra\" earnings into an intrinsic value per share.</p> <p>For Huntington Bancshares, the inputs are quite specific. Book value is $13.78 per share and the stable earnings per share are estimated at $1.92, based on weighted future Return on Equity estimates from 12 analysts. The average Return on Equity used in the model is 12.18%, while the cost of equity is $1.13 per share, leaving an excess return of $0.79 per share.</p> <p>The model also uses a stable book value of $15.78 per share, again sourced from weighted future book value estimates from 12 analysts. Combining these with the Excess Returns framework produces an estimated intrinsic value of about $37.01 per share.</p> <p>Compared with the recent share price of $17.54, this Excess Returns valuation implies the stock is 52.6% undervalued based on these assumptions and inputs.</p> <p><strong>Result: UNDERVALUED</strong></p> <p>Our Excess Returns analysis suggests Huntington Bancshares is undervalued by 52.6%. Track this in your <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a>, or discover <a class=\"company-report-links\" data-vars-link-type=\"cta_dcf_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">54 more high quality undervalued stocks</a>.</p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/banks/nasdaq-hban/huntington-bancshares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"HBAN Discounted Cash Flow as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/fc00b70e-27c3-4226-b098-c7e01a84dee7/chart/dcf?date=2026-02-27\" width=\"746\"/></a><figcaption>HBAN Discounted Cash Flow as at Feb 2026</figcaption></figure> <p><a class=\"company-report-links\" data-vars-link-type=\"dcf_explainer_cta\" href=\"https://www.simplywall.st/stocks/us/banks/nasdaq-hban/huntington-bancshares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Huntington Bancshares.</a></p> <h3>Approach 2: Huntington Bancshares Price vs Earnings</h3> <p>For a profitable bank like Huntington Bancshares, the P/E ratio is a useful shorthand for how much investors are paying for each dollar of current earnings. It ties the share price directly to the earnings stream that ultimately supports dividends and retained capital.</p> <p>What counts as a \"normal\" or \"fair\" P/E usually reflects what investors expect for future growth and how much risk they see in those earnings. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth or greater uncertainty often points to a lower multiple.</p> <p>Huntington Bancshares currently trades on a P/E of 17.06x. That is above the Banks industry average of 11.75x and also above the peer group average of 13.23x. Simply Wall St‚Äôs Fair Ratio for Huntington Bancshares is 16.67x, which is a proprietary estimate of what the P/E could be given factors such as earnings growth profile, profit margins, industry, market cap and key risks.</p> <p>Compared with simple peer or industry comparisons, the Fair Ratio aims to be more tailored because it adjusts for those company specific drivers rather than assuming all banks deserve the same multiple. With the actual P/E of 17.06x sitting modestly above the Fair Ratio of 16.67x, the shares screen as slightly expensive on this metric.</p> <p><strong>Result: OVERVALUED</strong></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/banks/nasdaq-hban/huntington-bancshares/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:HBAN P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/fc00b70e-27c3-4226-b098-c7e01a84dee7/chart/pe-multiple-vs-industry?date=2026-02-27\" width=\"746\"/></a><figcaption>NasdaqGS:HBAN P/E Ratio as at Feb 2026</figcaption></figure> <p>P/E ratios tell one story, but what if the real opportunity lies elsewhere? <a class=\"company-report-links\" data-vars-link-type=\"cta_preferred_multiple_contextual\" href=\"https://simplywall.st/discover/investing-ideas/473625/top-founder-led-companies/us\" rel=\"noopener noreferrer\" target=\"_blank\">Start investing in legacies, not executives. Discover our 19 top founder-led companies</a>.</p> <h3>Upgrade Your Decision Making: Choose your Huntington Bancshares Narrative</h3> <p>Earlier we mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach a clear story to your numbers by linking your view of Huntington Bancshares' future revenue, earnings and margins to a forecast and then to a fair value. This updates automatically as new news or earnings arrive and gives you an easy way to compare that fair value to the current price. For example, one Narrative on the Community page currently anchors on a fair value of US$10.11 with relatively modest growth assumptions, while another uses a fair value of US$20.50 with stronger revenue growth and higher profit margins. This shows how two investors looking at the same bank can use different Narratives to decide whether the current price around the high teens looks closer to an opportunity or something to watch.</p> <p>For Huntington Bancshares however, we will make it really easy for you with previews of two leading Huntington Bancshares Narratives:</p> <p><a href=\"/us/banks/nasdaq-hban/huntington-bancshares/kwqtp1w8-hban-cadence-bank-acquisition-will-drive-southeast-and-texas-market-expansion?utm_medium=finance_user&amp;utm_campaign=cta_bull_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêÇ Huntington Bancshares Bull Case</strong></a></p> <p>Fair value in this bull case Narrative: US$20.50 per share</p> <p>Implied valuation gap: about 14.4% undervalued versus the recent US$17.54 share price</p> <p>Revenue growth assumption: 18.98% per year</p> <ul> <li>Focuses on expansion into higher population growth regions like Texas and the Carolinas, with acquisitions and organic growth increasing fee income and loan opportunities.</li> <li>Assumes continued progress in digital banking, payments, and efficiency initiatives, which support non interest income, margins, and operating leverage.</li> <li>Builds in analyst expectations for revenue and earnings growth through to 2028, with a P/E multiple above the current US Banks industry average, and treats the current share price as close to fairly priced against the consensus target.</li> </ul> <p><a href=\"/us/banks/nasdaq-hban/huntington-bancshares/7lloaipr-overvalued-hban?utm_medium=finance_user&amp;utm_campaign=cta_bear_narrative_link&amp;utm_source=post\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><strong>üêª Huntington Bancshares Bear Case</strong></a></p> <p>Fair value in this bear case Narrative: US$10.11 per share</p> <p>Implied valuation gap: about 73.4% overvalued versus the recent US$17.54 share price</p> <p>Revenue growth assumption: 1%</p> <ul> <li>Points to a fair value that sits well below the current share price, with a future P/E ratio of 11x and modest revenue growth assumptions.</li> <li>Highlights that analyst targets cluster around an upper teens share price with only moderate expected upside from prior levels, while current pricing already reflects much of that view.</li> <li>Frames Huntington Bancshares as only modestly attractive for value focused investors under this set of assumptions, given the relatively low growth outlook used in the model.</li> </ul> <p>If you want to see how these Narratives are built, you can use them as a starting point, then tweak the revenue growth, margins, and required return until the story lines up with your own expectations for Huntington Bancshares.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_generic_community_narrative\" href=\"https://simplywall.st/features/community-narratives\" rel=\"noopener noreferrer\" target=\"_blank\">Curious how numbers become stories that shape markets? Explore Community Narratives</a></p> <p>Do you think there's more to the story for Huntington Bancshares? <a class=\"company-report-links\" data-vars-link-type=\"cta_create_narrative_community\" href=\"https://simplywall.st/stock/NasdaqGS/HBAN\" rel=\"noopener noreferrer\" target=\"_blank\">Head over to our Community to see what others are saying!</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/banks/nasdaq-hban/huntington-bancshares\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NasdaqGS:HBAN 1-Year Stock Price Chart\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/fc00b70e-27c3-4226-b098-c7e01a84dee7/chart/quote-price?date=2026-02-27\" width=\"746\"/></a><figcaption>NasdaqGS:HBAN 1-Year Stock Price Chart</figcaption></figure> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Huntington Bancshares might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/banks/nasdaq-hban/huntington-bancshares/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 07:56:30",
            "link": "https://simplywall.st/stocks/us/banks/nasdaq-hban/huntington-bancshares/news/is-huntington-bancshares-hban-pricing-look-attractive-after",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "Nomad Foods (NYSE:NOMD) Margin Hit And Quarterly EPS Loss Challenge Bullish Profitability Narratives",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Nomad Foods (NYSE:NOMD) closed FY 2025 with fourth quarter revenue of ‚Ç¨773.1 million and a basic EPS loss of ‚Ç¨0.07, capping a trailing twelve month revenue line of about ‚Ç¨3.0 billion and EPS of ‚Ç¨0.91 as margins compressed from a 7.3% net profit margin to 4.5% over the year. Over recent quarters, the company has seen quarterly revenue move from ‚Ç¨793.4 million in Q4 2024 to ‚Ç¨760.1 million in Q1 2025, ‚Ç¨746.9 million in Q2 2025, ‚Ç¨752.4 million in Q3 2025 and ‚Ç¨773.1 million in Q4 2025. Basic EPS shifted from ‚Ç¨0.32 to ‚Ç¨0.21, ‚Ç¨0.37, ‚Ç¨0.39 and then into a small loss. For investors, the latest print points to a business that is keeping the top line broadly steady while profitability and margins have come under pressure.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/us/food-beverage-tobacco/nyse-nomd/nomad-foods\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for Nomad Foods.</a> <p>With the recent numbers on the table, the next step is to see how this set of results lines up with the prevailing narratives around Nomad Foods, highlighting where the story is backed by the data and where it starts to look out of sync.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/wy9jtppy-revenue-challenges-will-weigh-on-frozen-sectors-though-margins-improve\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about Nomad Foods</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/us/food-beverage-tobacco/nyse-nomd/nomad-foods/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:NOMD Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/5ec22afb-1e93-49ba-b1a4-bdb0eb83fc01/chart/revenue-and-expenses-breakdown?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:NOMD Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Margins Squeezed by One Off ‚Ç¨78.4m Hit</h2> <ul> <li>Over the last 12 months, Nomad Foods earned ‚Ç¨136.7m of net income on about ‚Ç¨3.0b of revenue, but that includes a one off loss of ‚Ç¨78.4m and a move in net margin from 7.3% to 4.5%.</li> <li>Bears argue that repeated guidance cuts and reliance on cost cutting point to fragile profitability, and the reported one off loss and lower margin give that view some backing, although:\n    <ul> <li>Trailing net income of ‚Ç¨136.7m is still positive, which sits against bearish worries that earnings could be at risk if cost pressures persist.</li> <li>The 4.5% margin, while lower than 7.3%, is being weighed down by that ‚Ç¨78.4m item, so part of the pressure the bearish narrative focuses on is tied to a specific event rather than the entire ongoing cost base.</li> </ul> </li> </ul> A lot of cautious investors point to these compressed margins as a red flag, so if you want to see how that concern plays out over different scenarios, have a look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/wy9jtppy-revenue-challenges-will-weigh-on-frozen-sectors-though-margins-improve\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª Nomad Foods Bear Case</strong></a> to see how skeptics frame the longer term risks.\n\n<h2>Interest Coverage Weakens Even With TTM Profit</h2> <ul> <li>Interest coverage is flagged as weak, meaning current earnings do not comfortably cover interest payments, even though trailing 12 month net income stands at ‚Ç¨136.7m and EPS at ‚Ç¨0.91.</li> <li>Consensus narrative talks about cost savings and future margin improvement, but the interest coverage issue is an important counterpoint because:\n    <ul> <li>Lower net margin at 4.5% leaves less room to absorb financing costs, which is exactly what critics highlight when they point to financial vulnerability.</li> <li>The presence of that large ‚Ç¨78.4m loss in the same period makes it harder to tell yet whether future margins will be strong enough to comfortably improve coverage, so the optimistic margin story still has to be proven against the current figures.</li> </ul> </li> </ul> <h2>P/E Of 10.2x Versus DCF Value And Targets</h2> <ul> <li>Nomad Foods trades on a trailing P/E of 10.2x at a share price of US$11.26, which is below the US food industry average of 24.5x and peer average of 21x, and also below a DCF fair value of about US$28.48 and an allowed analyst price target reference of US$16.95.</li> <li>Bulls point to product development and efficiency programs as support for higher future earnings, and the current valuation gap feeds into that case because:\n    <ul> <li>The difference between the share price of US$11.26 and the DCF fair value of about US$28.48 suggests the market price sits well under that cash flow based estimate, which bullish investors see as room for upside if earnings forecasts play out.</li> <li>Forecast earnings growth of around 27.3% per year cited in the analysis is much stronger than the 0.3% annual revenue growth over the last year, so bulls are effectively arguing that profit improvement, not recent top line trends, will be the main driver of value.</li> </ul> </li> </ul> If you are trying to weigh that gap between today‚Äôs low P/E and the more optimistic fair value arguments, the <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/23lqvsmt-growing-european-urban-lifestyles-will-support-premium-frozen-foods\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ Nomad Foods Bull Case</strong></a> lays out how bullish investors connect these earnings and valuation numbers.\n<h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/wy9jtppy-revenue-challenges-will-weigh-on-frozen-sectors-though-margins-improve\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for Nomad Foods on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>The mix of margin pressure, valuation gaps and interest coverage concerns is a lot to process, so it is worth checking the numbers yourself and forming your own view while the information is fresh. To help you balance both sides of the story, take a look at the <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/food-beverage-tobacco/nyse-nomd/nomad-foods\" rel=\"noopener noreferrer\" target=\"_blank\">4 key rewards and 3 important warning signs</a> that our analysis has surfaced for this company.</p> <h2>See What Else Is Out There</h2> <p>Nomad Foods is working with compressed margins, a recent quarterly loss and weaker interest coverage, which together highlight pressure on profitability and financial resilience.</p> <p>If that mix of thinner margins and tighter interest cover makes you want sturdier foundations, check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> to quickly focus on companies with stronger financial footing today.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Nomad Foods might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/food-beverage-tobacco/nyse-nomd/nomad-foods/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 07:56:30",
            "link": "https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-nomd/nomad-foods/news/nomad-foods-nysenomd-margin-hit-and-quarterly-eps-loss-chall",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "A Look At Edison International (EIX) Valuation After Analyst Caution Strong Results And Bond Offering",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>Edison International (EIX) is back in focus after a mix of cautious analyst calls, a US$549.1 million fixed income raise, and detailed 2025 results paired with fresh earnings guidance through 2027.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-eix/edison-international\" rel=\"noopener noreferrer\" target=\"_blank\">See our latest analysis for Edison International.</a></p> <p>The recent mix of earnings guidance, fresh bond issuance and ongoing wildfire related headlines has come alongside strong momentum. A 30 day share price return of 18.75% and a 1 year total shareholder return of 53.96% suggest interest has been building rather than fading.</p> <p>If this kind of steady utility story has your attention, it could be a good moment to scan beyond Edison International and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_power_grid\" href=\"https://simplywall.st/discover/investing-ideas/473750/power-grid-technology-stocks/global\" rel=\"noopener noreferrer\" target=\"_blank\">23 power grid technology and infrastructure stocks</a> as potential next ideas on your list.</p> <p>The stock now trades just above the consensus analyst price target, with strong recent returns and upbeat earnings guidance already reflected in the share price. Investors may want to consider whether there is still a buying opportunity or if the market has already priced in future growth.</p> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Most Popular Narrative: 10.4% Overvalued</h2> <p>At $74.37, Edison International sits above the most followed fair value estimate of $67.37, which is built on detailed revenue, margin and risk assumptions discounted at 7.79%.</p> <blockquote> <p><em>Policy-driven increases in electrification, particularly accelerated electric vehicle adoption and grid-dependent building decarbonization, are expected to drive sustained long-term load growth within SCE's service area, supporting higher grid usage and long-term revenue expansion.</em></p> <p><em>Significant state and federal investment, along with policy momentum for decarbonization, will underwrite large-scale grid modernization and renewable energy integration projects, providing Edison International with stable, above-inflation capital expenditure opportunities and growing its regulated rate base, supporting earnings and rate base-driven revenue growth.</em></p> </blockquote> <p><em><a class=\"company-report-links\" data-vars-link-type=\"cta_narrative_prompt_after_quote\" href=\"https://www.simplywall.st/narratives/6tykvi9x-analysts-weigh-growth-prospects-and-risks-as-edison-international-fair-value-estimate-rises\" rel=\"noopener noreferrer\" target=\"_blank\">Read the complete narrative.</a></em></p> <p>Curious how that long term grid build out translates into today‚Äôs fair value line? Revenue growth assumptions, margin shifts and the chosen earnings multiple all quietly sit under that $67.37 figure, and the full narrative spells out how they fit together.</p> <p><strong>Result: Fair Value of $67.37 (OVERVALUED)</strong></p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_ai_narrative\" href=\"https://www.simplywall.st/narratives/6tykvi9x-analysts-weigh-growth-prospects-and-risks-as-edison-international-fair-value-estimate-rises\" rel=\"noopener noreferrer\" target=\"_blank\">Have a read of the narrative in full and understand what's behind the forecasts.</a></p> <p>However, that fair value story could be challenged if wildfire liabilities escalate or if California revisits cost recovery rules in ways that strain returns.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"risks_narrative_cta\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-eix/edison-international\" rel=\"noopener noreferrer\" target=\"_blank\">Find out about the key risks to this Edison International narrative.</a></p> <h2>Another View: Earnings Multiple Sends a Different Signal</h2> <p>While the SWS DCF model points to overvaluation, the current P/E of 6.4x tells a different story when you compare it with the US Electric Utilities industry at 22.5x, the peer average at 21.5x, and an estimated fair ratio of 14.3x. That wide gap raises a simple question: is the market overreacting to EIX specific risks, or is the DCF simply more conservative about future cash flows?</p> <p><a class=\"company-report-links\" data-vars-link-type=\"alternate_preferred_multiple_cta\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-eix/edison-international/valuation\" rel=\"noopener noreferrer\" target=\"_blank\">See what the numbers say about this price ‚Äî find out in our valuation breakdown.</a></p> <p></p><figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st//stocks/us/utilities/nyse-eix/edison-international/valuation\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"NYSE:EIX P/E Ratio as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/28d5acea-c557-463d-b6ee-990aac788834/chart/pe-multiple-vs-industry?date=2026-02-27\" width=\"746\"/></a><figcaption>NYSE:EIX P/E Ratio as at Feb 2026</figcaption></figure><p> </p><h2>Next Steps</h2> <p>If the mix of optimism and caution here feels balanced but unresolved, do not wait around. Look through the underlying numbers, weigh the narrative, and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/us/utilities/nyse-eix/edison-international\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 4 important warning signs</a> to see the full spread of concerns and potential upsides for yourself.</p> <h2>Looking for more investment ideas?</h2> <p>If you stop with just one stock on your radar, you risk missing other opportunities that could fit your goals even better, so widen your search confidently.</p> <ul> <li>Target potential mispricings by scanning <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undervalued\" href=\"https://simplywall.st/discover/investing-ideas/473076/high-quality-undervalued-stocks/us\" rel=\"noopener noreferrer\" target=\"_blank\">54 high quality undervalued stocks</a> and see which names fit your preferred mix of quality and price.</li> <li>Lock in reliability by checking <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/us\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (41 results)</a> where financial strength sits at the center of the story, not as an afterthought.</li> <li>Get ahead of the crowd by reviewing our <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_undiscovered_gems\" href=\"https://simplywall.st/discover/investing-ideas/473622/high-quality-undiscovered-gems/us\" rel=\"noopener noreferrer\" target=\"_blank\">screener containing 24 high quality undiscovered gems</a> before everyone else starts paying attention.</li> </ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\">Valuation is complex, but we're here to simplify it.</h3><p>Discover if Edison International might be undervalued or overvalued with our detailed analysis, featuring <strong>fair value estimates, potential risks, dividends, insider trades, and its financial condition.</strong></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"/stocks/us/utilities/nyse-eix/edison-international/valuation\" target=\"_blank\">Access Free Analysis</a></div></div>",
            "pub_date": "2026-02-28 07:56:30",
            "link": "https://simplywall.st/stocks/us/utilities/nyse-eix/edison-international/news/a-look-at-edison-international-eix-valuation-after-analyst-c",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        },
        {
            "title": "SEB (ENXTPA:SK) Margin Compression To 1.6% Tests Bullish Earnings Recovery Narrative",
            "description": "<div class=\"sc-d08486b0-3 byoTNg\" data-cy-id=\"article-content\"><p>SEB (ENXTPA:SK) has wrapped up FY 2025 with second half revenue of ‚Ç¨4.4b and basic EPS of ‚Ç¨8.28, putting fresh numbers behind a year that also saw trailing twelve month revenue of ‚Ç¨8.2b and EPS of ‚Ç¨4.47. Over the past few periods, the group has seen revenue move from ‚Ç¨4.5b in H2 2024 to ‚Ç¨3.7b in H1 2025 and then ‚Ç¨4.4b in H2 2025. Basic EPS shifted from ‚Ç¨2.41 in H2 2024 to effectively flat at ‚Ç¨0.01 in H1 2025 before rebounding to ‚Ç¨8.28 in the latest half, leaving investors to weigh a low 1.6% trailing net margin against the potential rewards implied by the current ‚Ç¨52.15 share price and the earnings profile behind it.</p> <a class=\"company-report-links\" data-vars-link-type=\"cta_company_latest_analysis_earnings\" href=\"https://www.simplywall.st/stocks/fr/consumer-durables/epa-sk/seb-shares\" rel=\"noopener noreferrer\" target=\"_blank\">See our full analysis for SEB.</a> <p>With the headline numbers on the table, the next step is to line these results up against the most widely held narratives about SEB and see which stories the data supports and which ones start to look stretched.</p> <p><a class=\"company-report-links\" data-vars-link-type=\"cta_range_narrative\" href=\"https://www.simplywall.st/narratives/cu3l7dzj-analysts-lower-seb-valuation-after-weaker-guidance-and-softer-growth-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">See what the community is saying about SEB</a></p> <figure><a class=\"company-report-links\" data-vars-link-type=\"infographic\" href=\"https://www.simplywall.st/stocks/fr/consumer-durables/epa-sk/seb-shares/past\" rel=\"noopener noreferrer\" target=\"_blank\"><img alt=\"ENXTPA:SK Revenue &amp; Expenses Breakdown as at Feb 2026\" class=\"sc-3204b94-0 iJdSPa\" height=\"476\" loading=\"lazy\" src=\"https://images.simplywall.st/company/b48dca4c-76ed-4095-9b51-1126ce7caf17/chart/revenue-and-expenses-breakdown?date=2026-02-27\" width=\"746\"/></a><figcaption>ENXTPA:SK Revenue &amp; Expenses Breakdown as at Feb 2026</figcaption></figure> <div class=\"relative grid grid-rows-[25px_auto] place-items-center bg-surface @container/article-body-ad [[data-brand='v2']_&amp;]:bg-surface-1\" data-cy-id=\"article-body-ad\"><div class=\"text-tiny text-softer\">Advertisement</div><div class=\"relative h-[250px] min-h-[250px] w-[300px] min-w-[300px] @[380px]/article-body-ad:h-[280px] @[380px]/article-body-ad:min-h-[280px] @[380px]/article-body-ad:w-[336px] @[380px]/article-body-ad:min-w-[336px]\"><div data-fuse=\"news_incontent_1\" id=\"news_incontent_1\"></div></div></div><h2>Margins Feel Tight At 1.6% Net Level</h2> <ul> <li>Over the last 12 months, SEB earned ‚Ç¨244.6 million of net income on ‚Ç¨8.2b of revenue, which works out to a 1.6% net margin compared with 5% a year earlier.</li> <li>Consensus narrative talks about better margins over time, yet the latest 1.6% margin and the ‚Ç¨229.4 million one off loss show that current profitability is still thin compared with the higher margin profile analysts have in mind.\n    <ul> <li>Analysts are working with earnings today of ‚Ç¨132.7 million moving to ‚Ç¨529.7 million, so the current margin level is well below what that path assumes.</li> <li>With revenue growth at about 2.2% over the last year, the pressure on margins rather than top line is what stands out against the more optimistic margin expansion story.</li> </ul> </li> </ul> <h2>Valuation Signals Point In Different Directions</h2> <ul> <li>At a ‚Ç¨52.15 share price and a P/E of 21.8x versus peers at 20.4x and the industry at 15.8x, the stock trades on richer earnings multiples while sitting below a DCF fair value of ‚Ç¨193.35 and below an analyst target of ‚Ç¨75.64.</li> <li>Bulls highlight the gap between the ‚Ç¨52.15 price and both the ‚Ç¨75.64 target and the DCF fair value of ‚Ç¨193.35. However, the higher P/E than peers together with a 1.6% margin means the current valuation already reflects better earnings quality than the recent numbers actually show.\n    <ul> <li>The bullish case leans on earnings growing from ‚Ç¨132.7 million to ‚Ç¨544.2 million, yet trailing earnings were shaped by that ‚Ç¨229.4 million one off loss and weaker margins, which keeps the quality of the base year in focus.</li> <li>What stands out is that even with modest 2.2% revenue growth, the market is assigning a higher P/E than the industry, so any delay in the margin recovery that bulls expect could leave the stock looking expensive on current earnings.</li> </ul> </li> </ul> Have a look at how bullish analysts join the dots between these compressed margins and their longer term growth case for SEB. <a class=\"company-report-links\" data-vars-link-type=\"cta_bull_narrative_link\" href=\"https://simplywall.st/narratives/vegkxk4o-update-for-seb\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêÇ SEB Bull Case</strong></a> <h2>Debt, Cash Flow And The 5.31% Dividend</h2> <ul> <li>The company is paying a 5.31% dividend, while earnings and free cash flow are flagged as not covering that payout and operating cash flow is described as weak relative to debt obligations.</li> <li>Bears focus on this combination of a 5.31% yield with weak debt coverage, arguing it puts pressure on cash generation, and the trailing 1.6% margin plus the large one off loss back up that concern by showing how little buffer there was in the last 12 months.\n    <ul> <li>With ‚Ç¨8.2b of trailing revenue only turning into ‚Ç¨244.6 million of net income, there is not a big cushion to comfortably support both debt service and a high payout if earnings stay at these levels.</li> <li>Critics point out that if revenue growth stays close to the recent 2.2% rate while margins remain low, management may have limited room to both reduce debt and maintain the current dividend profile.</li> </ul> </li> </ul> If you are weighing that 5.31% yield against the debt and margin picture, it is worth seeing how skeptics frame the downside case. <a class=\"company-report-links\" data-vars-link-type=\"cta_bear_narrative_link\" href=\"https://simplywall.st/narratives/63terjg3-update-for-seb\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>üêª SEB Bear Case</strong></a> <h2>Next Steps</h2> <p>To see how these results tie into long-term growth, risks, and valuation, check out the full range of <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://www.simplywall.st/narratives/cu3l7dzj-analysts-lower-seb-valuation-after-weaker-guidance-and-softer-growth-outlook\" rel=\"noopener noreferrer\" target=\"_blank\">community narratives</a> for SEB on Simply Wall St. Add the company to your <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/stock-watchlist\" rel=\"noopener noreferrer\" target=\"_blank\">watchlist</a> or <a class=\"company-report-links\" data-vars-link-type=\"conclusion_cta_when_narratives_exist\" href=\"https://simplywall.st/features/portfolio\" rel=\"noopener noreferrer\" target=\"_blank\">portfolio</a> so you'll be alerted when the story evolves.</p> <p>If this mix of cautious and optimistic signals feels hard to balance, take a moment to look through the data yourself and form your own view, starting with <a class=\"company-report-links\" data-vars-link-type=\"cta_risks_rewards_analysis\" href=\"https://www.simplywall.st/stocks/fr/consumer-durables/epa-sk/seb-shares\" rel=\"noopener noreferrer\" target=\"_blank\">3 key rewards and 4 important warning signs</a>.</p> <h2>See What Else Is Out There</h2> <p>SEB is working with tight 1.6% margins, a large one off loss and a 5.31% dividend that is not covered by earnings or free cash flow.</p> <p>If stretched margins and a heavily committed payout make you uneasy, focus on companies with stronger cushions and check out <a class=\"company-report-links\" data-vars-link-type=\"cta_screener_solid_balance_sheet\" href=\"https://simplywall.st/discover/investing-ideas/10146/solid-balance-sheet-and-fundamentals/global\" rel=\"noopener noreferrer\" target=\"_blank\">solid balance sheet and fundamentals stocks screener (374 results)</a> today.</p> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.</em></p><div class=\"sc-80c0fb9d-0 hLZAWP\"><h3 class=\"m-0 text-balance text-mega font-medium mb-4 font-serif\"><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>‚Ä¢ Connect an unlimited number of Portfolios and see your total in one currency<br/>‚Ä¢ Be alerted to new Warning Signs or Risks via email or mobile<br/>‚Ä¢ Track the Fair Value of your stocks<br/></p><a class=\"sc-kuACkN kjLJKA !text-[--s-button-primary-color-text] !no-underline\" data-focus=\"dashed\" href=\"https://simplywall.st/features/portfolio\" target=\"_blank\">Try a Demo Portfolio for Free</a></div></div>",
            "pub_date": "2026-02-28 07:51:39",
            "link": "https://simplywall.st/stocks/fr/consumer-durables/epa-sk/seb-shares/news/seb-enxtpask-margin-compression-to-16-tests-bullish-earnings",
            "source": "simplywall",
            "kind": 1,
            "language": "en"
        }
    ]
}